Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Haemophilus influenzae 86-028NP, 86-028NP

>NTHI0122 conserved putative exported protein
MATNRLLKIVFSLIGLGVATHSVAFNGFGTDIDGYIKDASNRYQVDEAML
RGLVKIEDGWYGNVSPTGATGVGQFTRGTWNWLATTDEGRALGMTQITRY
NRDTPFDPRKNNQLNTLATALLARWHINQFFERGIKPSHENLYLAHNIGI
DGLHRALQGRATREDILNMKRNGMKKGMSVQGFLVYQSERFNVSKQIANF
QRPSVSPRYQIENKPLPANLHWVSPTETAMRWVEPASNQTNQQAIRWQNP
TN
>NTHI1085 predicted membrane bound zinc metalloprotease with PDZ domain
MSFLWSLGSFIIAIAVLVSVHEYGHFWAARKCGIKVHRFSIGFGKVIWKR
IDKYGTEFAVSMIPLGGYVKMLDGRNEVVPAEQKSQAFDSKSVLQRAFVI
IAGPLANFIFAIFAYWIIYLYGMPTVKPVIQSITPSSIAAQAHIEPNTQI
LAVDGEETQDWETINMLLATKMGEPNVEITLSPFNSNIEQQRTLNLTNWI
FDPEKESAFEALGIMPMRPKIEMVLSKVVQNSPAEKAGLQIGDKILKENL
TALPWQDFIKQVEQGESFSIKVERNGETFDKVLTPVRNQNGKWFVGVSPT
LTKLADEYRTELKYGILESLQKGIEKTGQLSLLTLKILGKLLTGDLSLNN
LSGPISIAKGAGASANIGLVYFLSFMALISVNLGIMNLFPLPVLDGGHLV
FLTMEAVKGKPVSERVQSICYRIGAALLLSLTVFALFNDFLRL
>NTHI0363 conserved hypothetical lipoprotein
MKKIILNLVTAIILAGCSSNPETLKATNDSFQKSETSIPHFSPLATGGVQ
LPKADDAYSLPNIEVKKGEDIDIRPPLIPLAIIQNSITKFDGERSLIVYP
KQQAKLYNLQQVKRLLKDEGISSTTDGSILTTDWAKTERIGDKSIEIKYQ
IEQVMTADVSVLTVSILHMRRDGIIFTPNVSDKQYYTSERLNRIVLTLTT
AYNKQLQDL
>NTHI1918 predicted phosphoglycerol transferase-like protein
MKKAHFPLFPIFTFVLINLIILSLSRLGLAVWQSERVSAVDGWLQLFLQG
VRMDVVALCYLFGVPALLTTLFHSSKVWVKILRLWLTLGSVFIIFMEIAT
PAFIETYDYRPNRLFIEYLIYPKEVFSMLAEGHLSAVIFSLVFTILAAVI
YWKISGWAVKNLGSISWKLRPVIALLVIVLSFLGARSSFQHRGINPAMVA
FSSDALVNSLVLNSGYSVIYAAQQFKDEEKSSEMYGKMDADEIFRIVKAS
RGRPESDYISDKYPTLTKNVATYQGKPKNIVILLQESLGAQFIGTLGGKP
LSPNVDQLAKEGWLFENLYATGTRSVRGIEATTAGFTPTPARAVVKLNNA
QSGFFTIADLLHKQGYNTSFIYGGEKHFDNMASFFYGNGFKDIWDQQDYQ
NPKFTGTWGVSDEDLFDKANETFTKLQNEGKPFFSLVFSSSNHDPFEYPD
GKIELYEQPKATRNNAAKYADYALGHFFKMAKQSNYWKDTIFLIVADHDS
RVGGASLVPIKHFHIPALILGDGITPRRDSRLVSQIDMPTTLLSLAGVSG
NYPMIGFDLTQDVNPDRAFMQYDQTQAMMKGNNDVVIQMSNKAAQGYHYD
KSTETLTPKDVPDAMKKEALAHALLGSYLYKNRLYSSGENK
>NTHI1874 probable bacteriophage tail completion protein gpR homolog
MDGGQIVATGAASFSFEYRYTLNVVVTDYAGDIATLIVPMMAYLRTNQPE
ILENPQIRENAFKFQIDYNNNNTADISFEIQLTERVVSKKDGNNVQIHYA
KEPVWDEPNRVKVYLENRDSPIFEGDTV
>NTHI2014 predicted choline-glycine betaine transporter
MTKRTSFNPLVIGVTLFFILLLMAMIFIAPEQTQALLNQAKSGIFANFSW
FYVLTFSVFLGFLLILSVSSLGNIKLGQDEEEPEFSFLSWLAMLFAAGMG
VGLMFFGVAEPLTHYLSDITVGSAEHKQQEALLHTLFHWGIHAWAVYGTI
ALALAYFGFRYKLPLALRSCFYPLLKDRINGKIGDAIDVMALLATLFGII
TTLGFGSSQLGAGLEQIGWISQNSFALQVGVIVVVMCLAVFSAISGIGKG
VKILSEINLTLAFCLLLFVLISGPTLYLLSAFSDNIGNYFSNLVQLSFKT
YAYEQEHTSWFSGWTVLYWAWWCSWAPFVGLFIARISKGRTIREFIFGVL
VIPSLFGILWFTVFGNTAVWLNDGIAAGGLGEFISSPEILLFKFLNYLPL
PTITGFVSLLVISLFFITSADSGIYVLNNIASRDKSLASPAWQAIMWGTL
MSVVAIVLMQSGGLANLQTMTLIVALPFALLMLVMCFSLWKGLIADKKYF
STKVNPTSIFWSGDKWKSHLEQMMNQTQEKDILRFLKNTALPAMRELRQE
LTGKYNLSVEINTLFEQEEPALELVIHKESMRDFMYGIKSVGREVSEQLI
NDENLPHIQHSVTYEPYTYFFDGRVGYDVQYMDQDELIADMLKQYERYLS
LLDDVGQELMAHEQTELAE
>NTHI0539 conserved hypothetical protein
MPIGGDVKADQETSGSRSIKRIGFGFIGGIGYDITPNITLDLDYRYNDWG
RLENVRFKTHEASFGVRYRF
>NTHI0509 possible starvation-inducible outer membrane lipoprotein
MKGKITLFFTALCLGLTGCIAPPKGLEKERFSINSYREISPQDLTCHCKT
VRLGGKIINTTVLANQTKIEVLSLPVSSISGKPFVELQSDGRFIVYFNGF
VEPENLKERYITVGGQLAGTEKGKIEQADYTYPVVQADKYRIWTLSTIYE
YPTDDWDEDDDWGFFRWRYRPWYVQPEIRYYLN
>NTHI0532 conserved hypothetical metalloprotease
MPVQHVKLARDRRKKRTYIKVGVFFVAILLILTGILLTIKDKSEENPIFS
TSDSGEYHELNTSPNKNSTALQPDEDATSYDDELQAKDDEVDEVKLSSDD
LGTLPQHAQDALNGLLDAADQAIRITDQFSYTVTEGDTLKDVLVLSGLDD
SSVQPLIKLDPELAHLKAGQQFYWILNKNDNLEYLNWLVSEKEERIYERL
EDGKFKRQVIEKKSIWRKEVLKGEIQNSLNSSLREQGLDTRQISQLSNAL
QWQVSLRKLKKGTQFAILVSREYLGDKLTGQGNVEALRISSGGKNYYAVQ
AANGRYYNQQGETLGKGFARYPLQRQARVSSPFNPNRRHPVTGRVRPHKG
VDFSVSQGTPVIAPADGTVEKVAYQAGGAGRYVMLRHGREYQTVYMHLSK
SLVKAGQTVKKGERIALSGNTGISTGPHLHYEFRINGRAVNPLTVKLPGT
SSGMTSAERKQFLVRVREAEKMLKP
>NTHI1084 protective surface antigen D15
MKKLLIASLLFGTTTTVFAAPFVAKDIRVDGVQGDLKQQIRASLPVRAGQ
RVTDNDVANIVRSLFVSGRFDDVKAHQEGDVLVVSVVAKSIISDVKIKGN
SIIPTEALKQNLDANGFKVGDVLIREKLNEFAKSVKEHYASVGRYNATVE
PIVNTLPNNRAEILIQINEDDKAKLASLTFKGNESVSSSTLQEQMELQPD
SWWKLWGNKFEGAQFEKDLQSIRDYYLNNGYAKAQITKTDVQLNDEKTKV
NVTIDVNEGLQYDLRSARIIGNLGGMSAELEPLLSALHLNDTFRRSDIAD
VENAIKAKLGERGYGSATVNSVPDFDDANKTLAITLVVDAGRRLTVRQLR
FEGNTVSADSTLRQEMRQQEGTWYNSQLVELGKIRLDRTGFFETVENRID
PINGSNDEVDVVYKVKERNTGSINFGIGYGTESGISYQASVKQDNFLGTG
AAVSIAGTKNDYGTSVNLGYTEPYFTKDGVSLGGNVFFENYDNSKSDTSS
NYKRTTYGSNVTLGFPVNENNSYYVGLGHTYNKISNFALEYNRNLYIQSM
KFKGNGIKTNDFDFSFGWNYNSLNRGYFPTKGVKASLGGRVTIPGSDNKY
YKLSADVQGFYPLDRDHLWVVSAKASAGYANGFGNKRLPFYQTYTAGGIG
SLRGFAYGSIGPNAIYAAQNGNSNSNSNGTFNKISSDVIGGNAITTASAE
LIVPTPFVSDKSQNTVRTSLFVDAASVWNTKWKSDKSGLDNNVLKSLPDY
GKSSRIRASTGVGFQWQSPIGPLVFSYAKPIKKYENDDVEQFQFSIGGSF
>NTHI0181 putative D-alanyl-D-alanine carboxypeptidase
MKLTLEMLTGKSREHLVNLPTTHSSNHFLQTQAMQAFQALQQSAAKNGFN
LQPASSFRDFERQKLIWNSKFKGERKVHDDAGKALDLNQLDDWQKCQAIL
RWSALPGASRHHWGTEVDIFDPDLLPQGQSLQLEPWEYEKGGYFFELSEF
LAENLPHFDFALPFMNMQSNKKVGREPWHISYLPLAELASQQFSPEILQQ
AWKGENILGADCLISHLEQIFSEYIV
>NTHI1826 putative effector of murein hydrolase
MQQYIIYLYTFLTIFGFWLALQISKRWKSMIFNTFVLTVLILAAILVIGK
IPYDDYMAGNAPINNLLGLSIVALALPLYEQLRQIARQWKIILSTVVIAS
FLAMLSGGLLAFLLGATPEMVATVLPKSITMPIAMEVSRHLGGIPAVTAV
GVVVAGLQGSIFGYLVLKKLGVKHQEAIGLSVGSVSHALGTVSCMETNPT
AGSYSSISLVLCGIISSILAPFVFKLIYFFV
>NTHI1075 conserved hypothetical protein
MRRMISGTVKPNFWSRLLLSIIAIFALPNAQSFENQNNTENYSSSVSIQQ
ALETVKVAREVQRQAIPQPSISRQTEKQPKIQPHFLADVLNLSAPIRAGP
LLI
>NTHI0173 conserved hypothetical protein
MSELLINDYTRKGFVDGLCVRLLTICIRPGKPNKATSSFVSSIIREPLHG
ETSICPVAEKMAFSFIKFLGKKKEEWALAITGYVVSIPIVLPILLIFIKA
ILDLGK
>NTHI0199 conserved hypothetical protein
MVKIERKATDSAYHEFTKILTSSAQLVAFLNQSDFVKARAKVENETVQQI
ASHFKFSQENNLNQLILSSFDRKEEDQLFVEYIRYVNNQARQTLNNELIT
KWKSLFEKRKITD
>NTHI1544 hypothetical protein
MSIVNLLFSALAGKRTTIGVLELDALLTENTSLSSQITEYPIEDGTVISD
HITRESERLSLSGVITGTGTLFNVGLGKYKLIAAKETLRELHAKRELVTI
VTGLDVYEDFAIESLEIERNSDDGERLNISAEFRKIQKVTLRKEEVPPEK
AAPNAKGKAGQTKVKTGKAQTGKPTNTQAQKITKFGEWTGKKE
>NTHI1750 putative glycosyl transferase, glycosyl transferase family 8 protein
MNIVFTLDCNFASHLDTVLKSLCYHHNNINIYVIHDGIPAESLEKLKMHC
AKFDNTLYDIQFNINQFSFPTVISPAHIQSTASLFRLYLHQILPQHIERV
IYLDMDLIIHQAIDELWDINLEDSLIAGVSDFFSEYLWEHPFYEKQQYIN
AGVMLINLNKWRENNIEQYFIEYAAKYGEFFVYGDQDVINFSIPTNLIKL
LPVKFNIQVKFIEYLWMEHKEKIKFTPHIIHYIGSNKPWLKEHSANSPRF
YNEEYLFYHHLSWDNLRQTDRQTDRQTDRQTDRQTEKYNPIALYVKVRLI
LTAFFLLEGKLH
>NTHI1059 predicted membrane-fusion protein
MSQTQHQRPKRSHIFLMKIILVVFVLIFVGVIGFNIIKGVMISRAIAEMP
ESSSPVTALEVQPREWTPVINTTGLVRPNQGALLSTQNAGTISQVLVQNG
QNVKKGEVLVELDSSVERANLQAAQAQLSALRQTYQRYVGLLNSNAVSRQ
EMDNAKAAYDAQLANIESLKAVIERRKIVAPFDGKAGIVKINVGQYVNVG
TEIVRVEDTSSMKVDFALSQNDLDKLHIGQRVTATTDARLGETFSARITA
IEPAINSSTGLVDVQATFNPEDGHKLLSGMFSRLRIALPTETNQVVVPQV
AISYNMYGEIAYLLEPLSEEEKGKMSGNEKLDRLYRAKQITVFTKDRQGV
YAQLQGNEVKAGDKIITGGQQGIGNGSLVEWIKKDIVGAVEPAHKTPL
>NTHI1459 hypothetical protein
MIFSKNKYPPLHEFTALMNRVDNFLNHDAENRIAYYKKRSGIDLEKDVYE
AICYCAQNTPFEDTISLVSGKHFPDIVASQYYGIEVKSTQGDKWTSIGSS
ILESTRIPNIEKIFLTFGKLGGNIKFLSKPYESCLCDIAVTHYPRYKIDM
LLEKGESIFEKMETTYDSLRELDNPITPVAKYYKSLLIEGESLWWTSNNV
LDDIAPPKVRHWKVIEKYERDMLIAQAYAFFPETILGNPRNKYDKFALWL
VTKHGVINTSLRDEFSAGGQQKITDTCGETHLCSAVLKRVENNILAIKKF
ILETPENILTELWGNYIKDDRITQWANLVLSYCKPSNHNEMKLILTKIVN
EKTIFNDKDDVNKLEEMAKIYITNQKINSL
>NTHI0821 conserved hypothetical protein
MKKKSLKLTALFLALSCFPAFAEQTVDIEVQGIRGFRAVRNTDLNVNLIN
KEEMDGSERYQHLVTKAVDRGLRVFGYYESSVRFERKQRQGKRDLLIAHV
TPGEPTKIAGTDVQIEGEAAQDENFNALRKNLPKDGVLVEHQTYDDYKTA
ISRLALNRGYFDGNFKISRLEISPETHQAWWRMLFDSGVRYHYGNITFSH
SQIRDDYLNNILNIKSGDPYLMNNLSDLTSDFSSSNWFSSVLVQPNINHK
SKTVDIEIILYPRKKNAMELGVGFATDGGVHGQIGWTKPWINSRGHSLRS
NLYLSAPKQTLEATYRMPLLKNPLNYYYDFAVGWEGEKENDTNTRVLTLS
ALRYWNNAHGWQYFGGLRTRYDSFTQADITDKTLLLYPTVGFTRTRLRGG
SFATWGDVQKITFDLSKRIWLSESSFIKVQASSAWVRTYAENHRIVARAE
IGYLHTKGIEKIPPTLRFFAGGDRSVRGYGYKKIAPKNKNGKLVGGSRLL
TASLEYQYQVYPNWWAATFADSGLAADNYTAKELRYGAGVGVRWASPVGA
IKFDIATPIRDKDNSKNIQFYIGLGTEI
>NTHI1921 possible polysaccharide biosynthesis protein
MNPFQKIKSAVNKCQRFFINRSLQRKLTNQGMTVISANCVGAFILHDLHQ
PFNSPFVNLCLSPQDFLRYLQNMDFYRTQPLTFVQTEKSYPVGKLADLEI
HFMHYHSEQEANEKWQLRTSRMKLDNLFIMMTDRDGVTEKDIQLFDQLPF
KNKVIFTHKPYPAFKSAYYIKGFEKQNQVGDIFEFSGWNGKKYYDQFDYL
KWFNQA
>NTHI0291 putative small-conductance mechanosensitive channel
MIRKLMKTPPFFTVLFASAMFTLSVSQGALGANSTNVLPTEQSLKADLAN
AQKMSEGEAKNTLLAELQTSIDLLQQIQAQQKINDALQTTLSHSESEIRK
NNAEIQALKKQQETATSTDYNAQSQDDLQNSLAKLNDQLQDTQNALGAAN
AQLAGQNSISERAQAALTENVVRTQQINQQLANNDIGSALRKQYQIELQL
IDLKNSYNQNLLKNNDQLSLLYQSRYDLLNLRLQVQQQNIIAIQEVINQK
NLQQSQNQLEQAQQQQQKTVQNDYIQKELDRNAQLGQYLLQQTEKANSLT
QDELRMRNILDSLTQTQHTIDEQISALQGTLVLSRIIQQQKQKLPTNLNI
QGLSKQIADLRVHIFDITQKRNELYDLNNYINKVESEDGKQFTEAERTQV
KTLLTERRKMTSDLIKSLNNQLNLAISLELTQQQITQISDQIQSKLEQQS
FWVKSNNPINLDWIKMLPRALIEQFNGMLKKLGFPTNYDNLPYLLMYFLG
LFIVGGAIFKFKNRIKQQLNKINREIHRLDTDSQWSTPLALLLTAFLTLS
STLWFLAVCQMIGFFFFKNPEEFWHWSFSMAGYWWFFTFWISLFRPNGIF
VNHFESSKENAQRFRGVIQRIIIVIVLLLNTSVFSNVTDAGLANDVLGQI
NTITALIFCAAIIAPRFNRVLRSYEPETNKHHWLIRIVQIGLRLIPVGLI
VLIVLGYYYTALNLIEHFIHSYIAWCVWWLVRNTIYRGITVSSRRLAHRR
LAEKRRQKALENNYENISSDDVVAVGEPEEGLALNDVRSQLLRFVDLFIW
TALLGIFYYVWSDLVTVVSYLREITLWQQTTTTDAGTVIESITLFNLLVA
LVILGITYVLVRNISGILEVLIFSRVNLSQGTPYTITTLLTYIFIAIGGA
WAFATLGMSWSKLQWLFAALSVGLGFGMQEIFANFVSGIILLFERPIRVG
DVVTINGVSGTVAKIRIRAITLIDFDRKEIIVPNKSFVTGQVTNWALSST
MTRLVISVGVAYGSDLTLVRQLLLQAADEQPTVLRDPKPSAYFLTFGAST
LDHELRVYVEQVGDRTSTTDAINRRINELFAEHNIDIAFNQLDVFIKNND
TGEEIPFVDVKK
>NTHI1627 conserved hypothetical lipoprotein
MKVYKSFLIATASLFLFACSSFQNDDYAMNYKGQIGDPIMAIAMLSEQQH
EWAGTPYVLGGVSRRGVDCSGFVQKTFFDRFNLRLPRSTVEQANYGKHVR
KEHIQTGDLIFFKTGRGPNGYHVGIYVKEDKFLHASTRGGVVYSSMNNPY
WSKAFWQVRRI
>NTHI1668 conserved hypothetical protein
MFKMKNITLALLMSGALVGCANIGDSYQASLEDYKQYEEITKQYNVKENW
WSLYDDAQLNRVIEQALTNNKDLAKAAVAVNRALYSANLVGANLVPAFNG
STSSAAQRRVDISTNSATSHKGSLNVSYTLDLWQRLANTVDAAEWSHKAT
AEDMESARLSLINSVVTTYYQIAYLNDAISTTNETIKYYTDIGNIMQTRL
AQGVADAASVDQAQQAILTARNNKLNFETQRKTAEQTLRNLLNLKPNEAL
NITFPHIMNVKTAGVNLNVPVSVIANRPDVKAAQFRLSSAFKNAKATQKS
WFPEVNLGASLSSTASTVGTALHNPVAAGTVGISLPFLNWNTVKWNVKIS
EADYETARLNYEQRITTALNNVDTNYFAFTQAQSTLSNLQQTHSYNQRIT
QYYRNRYNAGVSELREWLVAANTEKSSQLAILNAKYQVLQSENAVYSSMA
GYYL
>NTHI1091 conserved predicted lipoprotein
MKYLHFTRPTIKVIFMINSIKTLLLIATLAILSACGWHFQQSVTMPNEWR
TLALESDDSYNDFTVIMRRKLQENQVNVVNLEQNIPILRINKQITSDQVA
SIFKHGREAEKLLMLEVEATFRLANGESYPINAKVNRTFFDNARAALAKS
EEREVIWNDMREQVARQLIVKIIALQNQIKRK
>NTHI0252 conserved hypothetical lipoprotein
MALVNKIKTLSSVGILAATLFLAGCQAQSNILAFTPPVPSASMNVNRTAV
VSVTTKDSRTIQEIASYTKHGELIKLNASPSVTQLFQQVMQQNLISKGFR
IGQLNGSNAWVTVDVHEFGTQVEQGNLRYKLNTKIQATVYVQGAKGSYNK
SFNVTRSQEGVFNADNDEIHKVLSQTFNDIVNNIYQDQEVAAAINQYSN
>NTHI0338 predicted soluble lytic transglycosylase fused to an ABC-type amino acid-binding protein
MVFPWQFLRHTEENHYTAIQARGSLYVGTINNQISYFINKDSERGFEYEL
AKAFADTLGVELEMKIFDNQEQLFDELDKHNIDLAAAHLLYHPKNAERFQ
IGPAYHSASWQLAYRKNENRPKNLGNVKKDIYISNNLALEETLKELQKQY
PQLTWKRNQALTQEELLLQLAEGKIPYVIANSIDIAAIQQIKPELAIAFD
ITDEANVHWYLPNSPYRDLQTALLNFMNNAEETGLLDNLKEKYLGHISQF
DYVDTRSYMNAIENTLPQFSPLFEKYKGELDWRLLAAVAYQESHWNPDAT
SPTGVRGIMMLTKNTAQHMKISDRTDPEQSIKAGSEYLHWLISQLPESIE
KEERIWFALVAYNIGLGHLIDARRLTQNLGGNPDNWLNVKKNLPLLAEKR
YYSQLKYGYARGYEAYQYVENIRRYMNSIVNYHRVQENQTTNDNANNESA
VKNLEEIKENKD
>NTHI1476 alr, alanine racemase
MNVKPATAKISSHALKQNLEIIKQKAPNSKIIAVVKANAYGHGVVFVAST
LEQNVDCFGVARLEEALALRSNGITKPILLLEGFFNEQDLPILAVNNIET
VVHNHEQLEALKRSNLPSPIKVWLKIDTGMHRLGVALDEVDYFYQELKKL
PQIQPHLGFVSHFSRADELESDYTQLQINRFLSATKDKQGERTIAASGGI
LFWPKSHLECIRPGIIMYGISPTDTIGKEFGLTPVMNLTSSLIAVRHHKQ
GDPVGYGGIWTSPRDTKIGVVAMGYGDGYPRDVPEGTPVYLNGRLVPIVG
RVSMDMLTVDLGADSQDLVGDEVILWGKELPIETVAKFTGILSYELITKL
TPRVITEYVD
>NTHI0079 amiB, probable N-acetylmuramoyl-L-alanine amidase AmiB precursor
MKTKILFFLFFSTFSFSIFAAPITIAIDPGHGGKDPGAISRNLGIYEKNV
TLSIAKELKALLDKDPHFRGVLTRKSDYYISVPERSEIARKFKANYLISI
HADSSESPDRRGASVWVLSNRRANDEMGQWLEDDEKRSELLGGAGKVLSH
NNDKYLDQTVLDLQFGHSQRTGYVLGEHILHHFAKITTLSRSTPQHASLG
VLRSPDIPSVLVETGFLSNSEEEKKLNSQTYRRRIAYMIYEGLVAFRSGK
TNTLVKDNLVQNIKQNDIKKSGKNNRTSEQNINEDNIKDSGIRHIVKKGE
SLGSLSNKYHVKVSDIIKLNQLKRKTLWLNESIKIPDNVEIKNKSLTIKE
NDFHKKQNSSVNNTNKDLKKEKNTQTNNQKNIIPLYHKVTKNQTLYAISR
EYNIPVNILLSLNPHLKNGKVITGQKIKLREK
>NTHI0413 cutE, apolipoprotein N-acyltransferase
MKNLNRILLSIKFMNKYLTYFIAFISGLVGVFAFSPFDYWPLAYVSLLGL
LYVAKNPKKSTALLSTFLWAMGFFCFGVSWLNVSIHQFGGASLGVSYFLV
GLLAAYLALYPMLFTYLVQRFKVQSAVIFAVIWTLTEFLRGWIFTGFPWL
QFGYTQIDSPFYGLAPIFGVTGLTFFTLWASAVIFNLVSSLFKTKNFKLV
LANALLLIIVGGLSAYSSRIHFVKSVENKAISVTLAQGNIEQNLKWDPNY
FYSTLAIYQKLIAENLGKTDLIILPESALPTLENAITPFFEKLEHAAKET
KTEIMIGTVFQDTKSGKLLNSIMTTGNPDFPYQPDTPNRYNKHHLVPFGE
YVPLESILRPLNSVFNLPMSAFQSGEAVQPSLIAKKRAFSPAICYEIIFG
EQVRQNLKQDTDYLLTLSNDAWFGDSIGPWQHLQMARMRALELGKPLIRA
TNTGISVFVDAQGKVLAQAPQFIETTLTYKIAPAEGKTPYSVLGNMPLYA
LSLLFLLLHSMMAFIRRKMNIL
>NTHI0036 dacA, penicillin-binding protein 5 precursor
MLKRTTKIAFLSSFVALSAFSVSAEDMQFGVTPPQITAQTYVLMDYNSGA
ILTALNPDQRQYPASLTKMMTSYVVGVALKQGKIHNTDMVTIGESAWGRN
FPDSSKMFLDLNTQVSVADLNRGVIVVSGNDATVALAEHISGNVPNFVET
MNKYVQQFGLKNTNFTTPHGLDDPNQYSSARDMAIIGAHIIRDLPEEYKI
YSEKDFTFNKIKQANRNGLLWDKTINVDGMKTGHTSQAGYNLVASATTSN
NMRLISVVMGVPTYKGREVESKKLLQWGFANFETFKTLEAGKEISEQRVY
YGDKNSVKLGALMDHFITIPKGKQSEVKARYELADKNLQAPLAKGQVIGK
VVYQLDGKDIASANLQVMNDVGEAGIFGKLWDWLVLTVKGLFS
>NTHI1655 dacB, penicillin-binding protein 4 precursor
MKKLSSISTALGSFLLSVSFSLPTFANINVSDLTQKLPEGSNAGVIAKNI
NQNQIIADYNGSTFMLPASTQKVFTAVAAKLALGDQFQFETALLSNGKIQ
NGNLDGNLIVSFTGDPDLTRGQLYSLLAELKKQGIKKINGDLVLDTSVFS
SHDRGLGWIWNDLTMCFNSPPAAANIDNNCFYAELDANKNPGEIVKINVP
AQFPIQVFGQVYVADSNEAPYCQLDVVVHDNNRYQVKGCLARQYKPFGLS
FAVQNTDAYAAAIIQRQLRKLGIEFNGKVLLPQKPQQGQLLAKHLSKPLP
DLLKKMMKKSDNQIADSLFRAVAFNYYKRPASFQLGTLAVKSILQKQGIR
FGNSILADGSGLSRHNLVAPKTMLSVLEYIAKNEDKLHLMETFPIAGVDG
TISGRGGLISPPLVKNVIAKTGSLKGVYNLAGFMTNARGEKVAFVQFING
YSTGDLESKTKRAPLVQFERNLYNELYKY
>NTHI0362 dapA, dihydrodipicolinate synthase
MSAQNPLFSGSIVALVTPMNHYGEVDFSCLEKLVEHHIEAGSNALVSVGT
TGESATLSIEENVKVIEKTVEFAKGRIPIIAGAGANATSEAITMTKLLRD
SGVAGCLSVVPYYNKPTQEGMYQHFKAIAECTDLPQILYNVPSRTGSDMK
PETVARLAEIENIVGIKEATGDVSRIVKIKQLAGKNFIVLSGNDTTGLEA
IKLGAEGVISVTNNIAAKDMADMCRYALAGDFDKAEEINARLMRLHHDLF
IESNPIPVKWAAYRLGLIKSPHLRLPLTTLSEEIQPKVEDALKIAGLL
>NTHI1308 ddlB, D-alanine--D-alanine ligase
MNLKQEKIAVLLGGTSAEREVSFNSGKAVLEALLKQGYNAHPIDPKEYNV
ANLKKDGFNRAFNILHGRGGEDGTMQGLLEQIGLPYTGCGVMASALTMDK
MRTKMLWKAFGLPVADMKVVTRETFSELDPQAVVAKLGLPLMVKPSLEGS
SVGLTKVKAVEELKSAVEYALKFDNTILIEEWLAGDELTVPVLDNQVLPA
IRIVPEGEFYDYEAKYISDNTQYFCPAGLTPEREQELAILVKRAYDALGC
RGWSRIDVMCDAKGNFRLVEVNTNPGMTSHSLFPKSAATVGISFEQLVVK
ILELSL
>NTHI0453 dgkA, diacylglycerol kinase
MYKTTGLTHLINSTKYSLQGLKSAFKNETAFRHECFLACILIPLTFFLGE
TKIEIILMISSVLLVMALELLNSAVEAVVDRIGTERHELSGRAKDQGSAS
VFIALCIVGIVWGGILFF
>NTHI1299 ftsI, peptidoglycan synthetase FtsI
MVKFNSSRKSGKSKKTIRKLTAPETVKQNKSQKVFEKCFMRGRYMLSTVL
ILLGLCALVARAAYVQSINADTLSNEADKRSLRKDEVLSVRGSILDRNGQ
LLSVSVPMSAIVADPKTMLKENSLADKERIAALAEELGMTENDLVKKIEK
NSKSGYLYLARQVELSKANYIRRLKIKGIILETEHRRFYPRVEEAAHVVG
YTDIDGNGIEGIEKSFNSLLVGKDGSRTVRKDKRGNIVAHISDEKKYDAQ
DVTLSIDEKLQSMVYREIKKAVSENNAESGTAVLVDVRTGEVLAMATAPS
YNPNNRVGVKSELMRNRAITDTFEPGSTVKPFVVLTALQRGVVKRDEIID
TTSFKLSGKEIVDVAPRAQQTLDEILMNSSNRGVSRLALRMPPSALMETY
QNAGLSKPTDLGLIGEQVGILNANRKRWADIERATVAYGYGITATPLQIA
RAYATLGSFGVYRPLSITKVDPPVIGKRVFSEKITKDIVGILEKVAIKNK
RTMVEGYRVGVKTGTARKIENGHYVNKYVAFTAGIAPISDPRYALVVLIN
DPKAGEYYGGAVSAPVFSNIMGYALRANAIPQDAEAAENTTTKSAKRIVY
IGEHKNQKVN
>NTHI1309 ftsQ, cell division protein FtsQ
MNILKRKTPQNIRFGEQKPKYYFHIRAFAVLLGVFFLLGVYFNWQSILEK
MDDKPISAFALVGQNTFTTADDIKESLLKMGELKGFWGQDVAPIQEQIEA
LPWVKGAIVRKMWPNRLSIWVSEYQPVAFWNQNQFVTLDGIVFQLPSVRL
TAKNLPYLGGPDYQSLKVIETWNQIYINLKSNNIMAKGINIDDRGAWQIQ
LDNDIVLKLGRGDWKSKLERFVTIYPQIDVPENKKIDYIDLRYTAGAAVG
MVDR
>NTHI0471 galE, UDP-glucose 4-epimerase
MAILVTGGAGYIGSHTVVELLNAGKEVVVLDNLCNSSPKSLERVKQITGK
EAKFYEGDILDRALLQKIFAENEINSVIHFAGLKAVGESVQKPTEYYMNN
VAGTLVLIQEMKKAGVWNFVFSSSATVYGDPKIIPITEDCEVGGTTNPYG
TSKYMVEQILCDTAKAEPKFSMTILRYFNPVGAHESGLIGEDPNGIPNNL
LPYISQVAIGKLAQLSVFGSDYDTHDGTGVRDYIHVVDLAVGHLKALQRH
ENDAGLHIYNLGTGHGYSVLDMVKAFEKANNITIAYKLVERRAGDIATCY
SDPSLAAKELGWVAERGLEKMMQDTWNWQKNNPKGYRD
>NTHI0976 galU, UTP--glucose-1-phosphate uridylyltransferase
MKAIIPVAGLGTRMLPATKAIPKEMLTLVDKPLIQYVVNECVAAGIKEIV
LVTHSSKNAIENHFDTSFELETMLEKRVKRQLLEEVRSICPKNVTIMHVR
QGNAKGLGHAVLCGRPLVGNESFAVMLPDVLLAEFSADQKKENLAAMIQR
FNETGASQIMVTPVPQENVSSYGVADCGGIELNGGESAKINSIVEKPSIE
DAPSNLAVVGRYVFSAAIWDLLEKTPIGVGDEIQLTDAIDMLIEKETVEA
FHMTGETFDCGDKIGYMEAFVEYGIRHEKLGKEFKSFIKNLAKTL
>NTHI0617 gidB, methyltransferase GidB
MKAKLVSLLAQANIKISDQQIQQLINLVNLLNKWNKAYNLTSVRDPQEML
VKHILDSLVVSPYLQGDRFIDVGTGPGLPGLPLAIINPSKQFVLLDSLGK
RISFIRNAIRELRLTNVTPVLSRVEEYQPEDKFDGVLSRAFASLKDMTDW
CHHLPKENGYFYALKGIYQEDEINELNKKYTIQKVIELSVPELIGERHLI
VLR
>NTHI0553 glmS, glucosamine--fructose-6-phosphate aminotransferase, isomerizing
MCGIVGAVAQRDVAEILINGLHRLEYRGYDSAGVAVINKQNELQRIRCLG
KVKALDEAVSEKPLIGGTGIAHTRWATHGEPSETNAHPHSSGTFAVVHNG
IIENHEELRELLKSRGYVFLSQTDTEVIAHLVEWEMRSTDSLLEAVQKSV
KQLTGAYGMVVMDSRHPEHLVAARSGSPLVIGLGIGENFLASDQLALLSV
TRRFIFLEEGDIAEITRRTVDIYDTHGNKAKREIHESNLENDAAEKGKFR
HFMQKEIYEQPTALINTMEGRINHENVIVDSIGNGAKGILEKVEHIQIVA
CGTSYNAGMVARYWFESLAGVSCDVEIASEFRYRKFVTRPNSLLITLSQS
GETADTLAALRLAKEKGYMAALTICNVAGSSLVRESDLAFMTRAGVEVGV
ASTKAFTTQLAALLMLVTALGKVKGHISVEKEREIIKAMQSLPAEIEKAL
AFDREIEALAEDFAEKHHALFLGRGAFYPIAVEASLKLKEISYIHAEAYA
AGELKHGPLALIDADMPVIVVAPNNELLEKVKSNIEEVRARGGQLYVFAD
KEAGFTPSEGMKIITMPKVNDIVAPIFYTIPMQLLSYYVALIKGTDVDQP
RNLAKSVTVE
>NTHI0762 glmU, bifunctional GlmU protein
MTKKALSAVILAAGKGTRMYSDLPKVLHTIAGKPMVKHVIDIAHQLGSEN
IHLIYGHGGDLMRTHLANEQVNWVLQTEQLGTAHAVQQAAPFFKDNENIV
VLYGDAPLITKETLEKLIEAKPENGIALLTVNLDNPTGYGRIIRENGNVV
AIVEQKDANAEQLNIKEVNTGVMVSDGASFKKWLARVGNNNAQGEYYLTD
LIALANQDNCQVVAVQATDVMEVEGANNRLQLAALERYFQNKQASKLLLE
GVMIYDPARFDLRGTLEHGKDVEIDVNVIIEGNVKLGDCVKIGAGCVLKN
VVIGNDVEIKPYSVLEDSIVGEKAAIGPFSRLRPGAELAAETHVGNFVEI
KKSTVGKGSKVNHLTYVGDSEIGSNCNIGAGVITCNYDGANKFKTIIGDD
VFVGSDTQLVAPVKVANGATIGAGTTITRDVGENELVITRVAQRHIQGWQ
RPIKKK
>NTHI0354 hap, adhesion and penetration protein Hap
MKKTVFRLNFLTACISLGIVSQAWAGHTYFGIDYQYYRDFAENKGKFAVG
AKDIEVYNKKGELVGKSMTKAPMIDFASVARSGYAALVGDQYIVSVAHNG
GYTNADFGAEGQNPDQHRFTYQIVKRNNYKPDQKHHYNGDYHMPRLHKFV
TESSPFDMTGSMKGQTYADKEKYPMRVRIGSGDQYWRNEQDKGTQVAEAY
GYLIAGNTHMQTGAGNGDVSLSGDVRKGNDYGPMPTAGSFGDSGSPMFIY
DATEKKWLINGVLRTGNPSLGRENTFQLVRKNYFDEIFSANLKTTIFDFR
TPKNQQNQHYTFHSKNDGSGTITSGAGKIYKVKLANYNLSMKGTEPVYTN
GGVNNYSPALSHGENLYFIDYGKGVLTFSNNIDQGAGGLYFEGDFIVSPT
HNETWKGAGISISDESTVIWKVNGVENDRLSKIGKGTLHIQAKGKNLGSI
SVGDGKVILEQQEDDQHKKQAFSEIGLVSGRGTVQLNDDKQFDTDKFYFG
FRGGRLDLNGHSLTFKRIQNTDEGAMIVNHNTTEVANVTITGNESIVLPN
GNNINKLNYSKEIAYNGWFGETDENKHNGRLNLIYKPTTEDRTLLLSGGT
NLKGDITQEGGTLVFSGRPTPHAYNHLNRPNELGRPQGEVVIDDDWINRT
FKAENFQIKGGSAVVSRNVSSIEGNWTISNNANATFGVVPNQQNTICTRS
DWTGLTTCKTENLTDTKVINSIPTTQINGSINLTDNATANVKGLAKLNGN
VTLTNHSQFTLSNNATQIGNIRLSDNSTATVDNANLNGNVHLTNSAQFYL
KNSHLSHQIQGDKGTTVTLENATWTMPSDTTLQNLTLNNSTVTLNSAYSA
SPNNTPRRRRRSLETETTPTSAEHRFNTLTVNGKLSGQGTFQFTSSLFGY
KSDKLKLSNDAEGDYILSVRNTGKEPETLEQLTLVESKDNQPLSDKLTFT
LENDHVDAGALRYVLVKNNGEFRLHNPIKEQELHNDLVRAEQAEQTLEAK
QVEPTAETQTSKAKVRLRRAVLPDTLPAQSLLNALEAKQAEPNAKTQKSK
AKTKKARSKRALRAVFSDPPPDQSQLDVLKAALEVINAQPQVGKERQAQE
KQGKQKDLISRYSNSALSELSATVNSMLSVQDELDRLFVDQAQSAVWTNI
AQDKRRYDSDAFRAYQQKTNLRQIGVQKALDNGRIGAVFSHSRSDNTFDE
QVKNHATLTMMSGFAQYQWGDLQFGVNVGAGISASKMAEEQSRKIHRKAI
NYGVNASYQFRLGQLGIQPYLGVNRYFIERENYQSEDVKVQTPSLAFNRY
NAGIRVDYTFTPTDNISVKPYFFVNYVDVSNANVQTTVNSTMLQQSFGRY
WQKEVGLKAEILHFQLSAFISKSQGSQLGKQQNVGVKLGYRW
>NTHI1606 htrB, lipid A biosynthesis lauroyl acyltransferase
MKNEKLPQFQPHFLAPKYWLFWLGVAIWRSILCLPYPILRHIGHGLGWLF
SHLKVGKRRAAIARRNLELCFPDMSENDREAILQENLRSVGMAIIETGMA
WFWSDSRIKKWSKVEGLHYLKENQKDGIVLVGVHFLTLELGARILGLHHP
GIGVYRPNDNPLLDWLQTQGRLRSNKDMLDRKDLRGMIKALRHEETIWYA
PDHDYGRKNAVFVPFFAVPDACTTTGSYYLLKSSQNSKVIPFAPLRNKDG
SGYTVSISAPVDFTDLQDETAIAARMNQIVEKEIMKGISQYMWLHRRFKT
RPDEKTPSLYD
>NTHI1164 iga1, IgA-specific serine endopeptidase
MLNKKFKLNFIALTVAYALTPYTEAALVRNDVDYQIFRDFAENKGKFSVG
ATNVEVRDNKNNNLGSALPKDIPMIDFSAVDVDKRIATLVNPQYVVGVKH
VGNGVGELHFGNLNGNWNPKFGNSIQHRDVSWEENRYYTVEKNNFSSELN
GKTQNNEKDKQYTSNKKDVPSELYGQALVKEQQNQKRREDYYMPRLDKFV
TEVAPIEASTTSSDAGTYNDQNKYPAFVRLGSGSQFIYKKGSHYELILEE
KNEKKEIIHRWDVGGDNLKLVGNAYTYGIAGTPYKVNHTDDGLIGFGDST
EDHNDPKEILSRKPLTNYAVLGDSGSPLFVYDKSKEKWLFLGAYDFWGGY
KKKSWQEWNIYKPQFAENILKKDSAGLLKGNTQYNWTSKGNTSLISGTSE
SLSVDLVDNKNLNHGKNVTFEGSGNLTLNNNIDQGAGGLFFEGDYEVKGT
SENTTWKGAGISVAEGKTVKWKVHNPQFDRLAKIGKGKLIVEGRGDNKGS
LKVGDGTVVLKQQTTTGQHAFASVGIVSGRSTVVLNDDNQVDPNSIYFGF
RGGRLDANGNNLTFEHIRNIDDGARLVNHNMTNASNITITGAGLITNPSQ
VTIYTPAITADDDNYYYVPSIPRGKDLYFSNTCYKYYALKQGGSPTAEMP
CYSSEKSDANWEFMGDNQNDAQKKAMVYINNRRMNGFNGYFGEEATKADQ
NGKLNVTFSGKSDQNRFLLTGGTNLNGELKVEKGTLFLSGRPTPHARDIA
NISSTEKDKHFAENNEVVVEDDWINRTFKATNINVTNNATLYSGRNVESI
TSNITASNKAKVHIGYKAGDTVCVRSDYTGYVTCHNDTLSTKALNSFNPT
NLRGNVNLTESANFTLGKANLFGTINSTENSQVNLKENSHWYLTGNSDVH
QLDLANGHIHLNNVSDATKETKYHTLNISNLSGNGSFYYWVDFTKNQGDK
VVVTKSAKGTFTLQVANKTGEPNHNELTLFDASNATERSGLNVSLANGKV
DRGAWSYTLKENSGRYYLHNPEVERRNQTVDTPSIATANNMQADVPSVSN
NHEETARVEAPIPLPAPPAPATGSAMANEQPETRPAETVQPTMEDTNTTH
PSGSEPQADTTQADDPNSESVPSETIEKVAENSPQESETVAKNEQKATET
TAQNDEVAKEAKPTVEANTQTNELAQNGSETEETQEAETARQSEINSTEE
TVVEDDPTISEPKSRPRRSISSSSNNINLAGTEDTAKVETEKTQEAPQVA
FQASPKQEEPEMAKQQEQPKTVQSQAQPETTTQQAEPARENVSTVNNVKE
AQPQAKPTTVAAKETTASNSEQKETAQPVANPKTAENKAENPQSTETTDE
NIHQPEAHTAVASTEVVTPENATTPIKPVENKTTEAEQPVTETTTVSTEN
PVVKNPENTTPATTQSTVNSEAVQSETATTEAVVSQSKVTSAEETTVAST
QETTVDNSGSTPQPRSRRTRRSAQNSYEPVELHTENAENPQSGNDVATQL
VLRDLTSTNTNAVISDAMAKAQFVALNVGKAVSQHISQLEMNNEGQYNVW
VSNTSMKENYSSSQYRHFSSKSAQTQLGWDQTISSNVQLGGVFTYVRNSN
NFDKASSKNTLAQANLYSKYYMDNHWYLAVDLGYGNFQSNLQTNHNAKFA
RHTAQFGLTAGKAFNLGNFAVKPTVGVRYSYLSNANFALAKDRIKVNPIS
VKTAFAQVDLSYTYHLGEFSITPILSARYDANQGSGKINVDRYDFAYNVE
NQQQYNAGLKLKYHNVKLSLIGGLTKAKQAEKQKTAEVKLSFSF
>NTHI1182 ispH, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MKIILANPRGFCAGVDRAISIVELALEIHGAPIYVRHEVVHNRFVVNGLR
DRGAIFVEELSEVPDGAIVIFSAHGVSQAVRQEAKDRNLKVFDATCPLVT
KVHMQVARASRKGTKAILIGHKGHPEVEGTMGQYSNEDGGIFLIEKVEDI
ARLPMQDNDDLTFMTQTTLSLDDTAETIAALKEKYPAIQGPHKNDICYAT
TNRQEAVRELAKLSDLVLVVGSKNSSNSNRLAELASRMGIKSQLLDDPSD
IQDDWFNDVKTIGITAGASAPEELVQSIISRLKEFGADTIEELQGLEENM
FFEVPKELRIKEVN
>NTHI1576 kdsA, 2-dehydro-3-deoxyphosphooctonate aldolase
MQNKIVKIGNIDVANDKPFVLFGGMNVLESRDMAMQVCEAYVKVTEKLGV
PYVFKASFDKANRSSIHSYRGPGMEEGLKIFQELKDTFGVKIITDVHEIY
QCQPVADVVDIIQLPAFLARQTDLVEAMAKTGAVINVKKPQFLSPGQMGN
IVEKIEECGNDKIILCDRGTNFGYDNLIVDMLGFSVMKKASKGSPVIFDV
THSLQCRDPFGAASSGRRAQVTELARSGLAVGIAGLFLEAHPNPNQAKCD
GPSALPLSALEGFVSQMKAIDDLVKSFPELDTSI
>NTHI0068 kdsB, 3-deoxy-D-manno-octulosonic acid cytidylyltransferase
MSFTVIIPARFASSRLPGKPLADIAGKPMIQHVFEKALQSGANRVIIATD
NENVADVAKNFGAEVCMTSVNHNSGTERLAEVVEKLAIPDNEIIVNIQGD
EPLIPPVIVRQVADNLAKFNVNMASLAVKIHDAEELFNPNAVKVLTDKDG
YVLYFSRSVIPYDRDQFMNLQDVQKVQLADAYLRHIGIYAYRAGFIKQYV
QWAPTQLENLEKLEQLRVLYNGERIHVELAKEVPAVGVDTAEDLEKVRAI
LAAN
>NTHI0772 kdtA, 3-deoxy-D-manno-octulosonic acid transferase
MWRFFYTSLLLICQPLILCFIGLLSVKSPRYRQRLAERYGFYGNVPCPPP
QGIFIHAASVGEVIAAIPLVRQLQQDYPHLSITFTTFTPTGSERVKATFG
DSVFHYYLPLDLPFSIHRFINFVQPKLCIVMETELWPNLIHQLFLRNIPF
VIANARLSARSAHRYGKIKAHLQTMWSQISLIAAQDNISGKRYATLGYPK
EKLNITGNIKYDLNTNDELLRKIDSLRTLWKQDRPIWIAASTHNGEDEII
LKSHRALLAKYPNLLLLLVPRHPERFNVVADLLKKEKFQFIRRSTNELPN
ENTQVILGDSMGELMLMYGISDIAFVGGSLVKHGGHNPLEPLAFKMPVIT
GKHTFNFPEIFRMLVEVQGVLEVNSTADSLERAVEALLNSKEARERLGNA
GYEVLMENRGALQRLLDLLKPYLERNV
>NTHI0585 lav, autotransported protein Lav
MKLEASKQASKQASKQASKQASKQASKQASKQASKQASKQASKQKFKKSF
IISLFFSILYTSPLLAVVDYTYDNSKLTNEQIERLKKLRDRNSEYWKKET
YLLKSPPSNFPDIPVLFPKDSSVPFENIDNSKAISFYDQKYTEDYLVGFA
QGFGVAKRNGDTEEPVRKYFKECLNTGNYNNDNCKANPLASSVSIKSDIF
TPRPTIKNSHINSEILAVGNYTELMLAAQPSASSWAEHLYSDPGLSLTVQ
DNSHVIGQTIDLGFLQLTNSLWEPRWNSNIDYLVTENAEIRFNTKNESLL
VEGYYAGGARFRFAYDLKDKAPETPVLTFEQNITGTSDIIFENPIDDLKS
LDGHQIVKVNGTADKNAFRLSGKYRKGIYTLSLQQRLEGFFTKLQERDDI
AIYAQQAQAANTLFALRLNDKNSDIFDRTLPRKGLWLRVIDGHSSQWVQG
KTAPLEGYRKGVQLGGEVFTWQNESNQFSVGLMGGQAEQRSTFRNPDTDN
LTTGNMKGLGAGVYATWHQLQDKQTGAYVDSWAQYQRFRHRINTEDGTER
FTSKGITASIEAGYNALLAEHLTGKGTQIRFYLQPQAQLTYLGVNGKFSD
SENSQVNLLGSRQLQSRVGVQAKAQFLLNKNIVIQPFAAVNTLYHSKPFG
VEIDGERRVINNKTAIESQFGIAVKIKSHLTLQATFNRQTGKHHHAKQGA
LNLQWTF
>NTHI0021 lepA, GTP-binding protein LepA
MKNIRNFSIIAHIDHGKSTLSDRLIQTCGGLSDREMEAQVLDSMDLERER
GITIKAQSVTLNYKAKDGETYQLNFIDTPGHVDFSYEVSRSLAACEGALL
VVDAGQGVEAQTLANCYTAIEMDLEVVPILNKIDLPAADPERVAEEIEDI
VGIDAMEAVRCSAKTGVGIEDVLEEIVAKIPAPEGDPNAPLQALIIDSWF
DNYLGVVSLVRIKNGVLRKGDKIKVMSTGQTYNVDRLGIFTPKQEDTTVL
ECGEVGWVVCAIKDILGAPVGDTLTHQHNSATEVLPGFKKVKPQVYAGLF
PVSSDDYEAFRDALGKLSLNDASLFYEPETSTALGFGFRCGFLGLLHMEI
IQERLEREYDLDLITTAPTVIYEVQLTNGEVVYVDSPAKLPPLNNIAEIR
EPIAECNMLVPQEYLGNVITLCVEKRGVQTNMVYHGNQIALTYEIPMGEV
VLDFFDRLKSTSRGYASLDYGFKRFQAADMVRVDIMINSERVDALALIVH
KDNSQYRGRELVEKMRELIPRQQFDIAIQAAIGNHIIARSTVKQLRKNVL
AKCYGGDVSRKKKLLQKQKEGKKRMKSLGNVEVPQEAFLAILHVGKDK
>NTHI0913 lex2B, UDP-glucose--lipooligosaccharideglucosyltransferase
MFITPIFIINLEKSTDRKAYMQAQFEQLFSNNLIQEIHFFDAIYGKSNPN
HPLFQRYNENKRLNAKGYPLTLGQLGCYASHYSMWEKCVELDYPIIVLED
DAKFKNNFLEVLDFINSDKNTFEFFWLQPDRLKNKRKLISNFGNLSIYQF
SKGFAGATGYYLTPQAARKFLTQSKEWYLTVDVTMDRFFENKVPPYAIVP
FCLEDDGEIESTIYEKQKKQRSLKIVIMRELFNLKTNIKRRIYNLFH
>NTHI1071 lgt, prolipoprotein diacylglyceryl transferase
MNSNYLLLPHFDPSIFTLGDSNIGLRWYGLMYLLGFVFARWLAVRRANRP
NSGWTVDQVDTLLFNGFMGVFIGGRVGDVFFYNLDHFLQEPLYLFRVWEG
GMSFHGGLIGVIVAMIWTSYSQKRNFWQTADFVAPLIPFGLGLGRIGNFI
NLELWGRETNVPWAMIFPNDPLLLPRHPSQLYEAFLEGLVLFAILNIFIK
KPRPMASVAGLFLIGYGVFRFIVEYVREPEVENFFGIITRGQALCLPMII
GGAFIMAWAYSRKSAVIK
>NTHI0365 lgtC, UDP-galactose--lipooligosaccharidegalactosyltransferase
MTDRQTDRQTDRQTINIIFSSDNHYAPYLAVSIFSIIKNTPEKINFYILD
MKINQENKTIINNLATAYFCKVFFLPVSEADFQNFPKTIDYISLATYARL
NLTKYIKNIEKAIYIDVDTLTNSSLQELWNIDIMNYYLAGCRDTFIDVKN
EAYKKSIGLEGYSYFNAGILLINLNKWKEENIFQKSINWMNKYNNVMKYQ
DQDILNGICKGKVKFINNRFNFTPTDRGLIKKKNLLHVKMPIVISHYCGP
NKFWHKKCSHLNCHIGNLLLKEMDKIIDIPSSWYDHFEKIPFLIKIKRLR
KRIKDKLIYGIY
>NTHI1474 lgtD, UDP-glcNAc--lipooligosaccharide N-acetylglucosamine glycosyltransferase
MENPPLVSVIVCAYNAEQYIDESISSIINQSYKNLEIIVINDGSTDLTLS
HLEEISKLDKRIKIISNKYNLGFINSLNIGLGCFSGKYFARMDADDIAKP
SWIEKIVTYLEKNDHITAMGSYLEIIVEKECGIIGSKYKTGDIWKNPLLH
NDICEAMLFYNPIHNNTMIMRANVYREHKLIFNKDYPYAEDYKFWSEVSR
LGCLANYPEALVKYRLHGNQTSSVYNHKQNEVAKKIKGENITYYLNKIGI
DIKVINSVSLLEIYHVDKSNKVLKSILYDMYMSLDKYTITSLLHFIKYHL
KLFDLKQNFKIIKKFIRKINVMF
>NTHI0773 lgtF, UDP-glucose--lipooligosaccharideglucosyltransferase
MPTISVAMIVKNEAQDLANCLDTVKDWVDEIIILDSGSTDNTKEIALSYG
AKFYENSDWQGFGKQRQLAQQYVTSDYVLWLDADERVTPKLQQAILSAVK
NDRENTVYEIPRVSEVFGREIRHSGWYPDYVVRLYRTNYAQYNDSLVHEK
VEFPAGTKVEKLTGDLEHFTYKSIHHYLVKSAGYAKAWADQRQAKGKKAT
LWQGISHALGCFVKMYLLKAGFLDGKQGFLLAVLSAHSTFVKYADLWERD
QHKH
>NTHI0677 lic2A, UDP-Gal--lipooligosaccharidegalactosyltransferase
MLIYSFRIVECKKFSYFHFYLNMSAIENIVISMENATERRKHITKQFESK
KLSFSFFNAYTYQSINQSINQSINQSINQSISILHNIEESRILTKGEKGC
LISHFLLWNKCVNENLEYLTIFEDDVILGENAEVFLAQDEWLKTRFDFND
IFIIRLETFLQPVKLEKQTKIPPFYSRNFDILKSTHWGTAGYIISQGAAK
YVIEYLKNIPSDEIVAVDELIFNKLVDVDNYIVYQLNPAICIQELQANQS
KSVLTSGLEKEREKRPKIRKKKTLKQRLTRIKENIIRALNRKKWKEQQRI
KEMQGKEIVRFM
>NTHI1597 licA, LicA
MQSINQSINQSINQSINQSINQIVGFVKTCYKPEEVFHFLHQHSIPFSSI
GGMTNQNVLLNISGVKFVLRIPNAVNLSLINREYEAFNNAQAYRAGLNVE
TPVLDAKSGVKLTRYLENSNTLSQIQLNEQSCLSQVVNNLYRLHNSEFVF
RNVFSVFDEFRQYFSLLENKSAFYQADSRMDKLSAVFWQFEEINKEIILR
PCHNDLVPENMLLQDDRLFFIDWEYSGLNDPLFDIATIIEEAHLSKEAAD
FLLETYCNQTNKYHKTEFQIAHKRLKIHRFCQNVLWFLWTKVKEEHGENF
GDYALKRLDAAFKLLEELP
>NTHI1595 licC, LicC
MNAIILAAGLGSRFKDITQSTHKSLLDIHGTPNLERTLTFLRQANIDNIV
IVTGYLHEQFEYLKKKYDCTLIYNEKYREYNSIYSFSLAQDFFSDCYVID
ADVVLNRNIFLTKPSHSKYFTVIRSKTHNEWLPILNSNGQVIRIEIGSLN
QSSLSGVSYWTTRDCDIILTLLKEYTSEVRLKNPKLYWDTIPMEYIEKLN
IYTEQLNSDDIFEMDNLDDYHHILQKLTPNKEK
>NTHI1594 licD, phosphorylcholine transferase
MKKLTLREQQLVCLNILDYFHALCERHQIHYSLGGGTLIGAIRHKGFIPW
DDDIDVYMHRDEYQRFVDVWFQETHEYYNMETAEDILAQYTGEMAKIFDC
RTQITDAKGRKSPMFMDIFIYDGVPNEPKIIYPLMKKHRRIKLRFSSCKK
RWLRSKENTLQRTILGKLSHFLFSKMQKNLAQFQIKYPIKQCDYIGLVLS
DYGGWQKSYMPKEYFNHIVYKEFEGRQFQVMNGYHEHLTQYYGDYMKLPP
EEDQKPHHIQEAYIL
>NTHI1456 lolA, outer-membrane lipoproteins carrier protein precursor
MKKTTLKFAALTLLGLSNLALADAASELQMRLAKVDVLSAEFVQTVTSGS
GKNVQQGSGKLQIKRPNLFRMETKTPQETQIISDGKTLWFYDPFVQQVTA
QWVKNAVNNTPFVLLTSNDNSHWHQYTVTQQSDTFVLKPTLSTSNIKQFD
IRVDANGILRNFSTTEKDGQTNLYVLRNITNQTLSDSLFQFKPEKGVEVD
DQRKK
>NTHI1435 lolB, Outer-membrane lipoprotein LolB
MNNMKTFKFLTALFATAILTACTLDMERPTNVQYIDKTDAIWQQHLQKIQ
KIQSYQAKGQIGYISPTERFSSRFEWQYQNPKSYTLKLYSLISKSTLLIQ
MHQSGMTISDNNDNQQSAANAKLLLQEIIGMDVPLEHLAYWLKGQPAMNA
DYQVGTNHLLGAFTYHVDGSQWTADYLTYHSNNSMPENILLKNDSTKQTL
KIRVDEWIY
>NTHI1578 lolC, lipoprotein releasing system transmembrane protein
MNFPISLYIALRYWRAKSADRFGRLVTNLASLGIVLGVMALIIVLSVMNG
LEGYQKQQVLSSIPHAIVSEEQPISTEKTLENLPHFVQKAVPINTTNVIY
QTAKGVSAGQIIGIQSFSDDPLVESFDQTKFNEILPRGEFKLVIGDQLAQ
KLGVNIGDKIRLMITENSQYTPFGRVPMQRLFTVSDIYYGYGEASGYEAF
ANITDIGRLMRIQPQQAQGYRLFLNDPFQITELPQHFPTQKITDWRVQKG
EFFQAVRMEKNMMGLLISLIIVVAISNIVTSLSLMVVDKQGEIAILQTQG
LTKSQVRSVFIYQGLLVGFVGTLLGAILGVLATLNLTDIVSAVNPQGVFL
PTELSFVQMIFVIGFSLLLSLLSTLYPAYRAAKVEPAAALRYE
>NTHI1586 lolE, ABC-type transport system, involved in lipoprotein release, permease component
MNTPFFISWRYQRGKQKNPLVALIAKFSAIGIALGVAVLIVGLSAMNGFE
RELNQRILAVVPHIEIFSAHQAKDPTIHHWQNLEKRLQQNPQIKGISPFV
SFTALVENGSKLKVVQVKGVEKQAEDKVSSIGNFVQEQGWNKFEKEGGLV
LGAGIAKELDVKVGDWITLLISQQNGDEQFAQPTREPVQVTAILRLDGQL
DYSYALLPLAQAQTFLTYQPDQITGVELKLDDPFSARNLDLSMLNDYPQM
LYMQNWISKFGYMYRDIQLIRTVMYIAMVLVIGVACFNIVSTLIMAVKDK
QGDIAIMRTLGANNAFIKRIFIWYGLQAGMKGCLIGIVLGIILALNLTTF
IQGIEWVIGKKLLSGDVYFVDFLPSELHWLDVLMVLVAALALSLMASLYP
ASRAAKLQPAQVLSSH
>NTHI0830 lppB, outer membrane antigenic lipoprotein B
MNKSFLLLPLSLVVLSACTSNSPAPISDADGNLSPSVVQSVNGSNVGGAW
QPEIQKNSLPTMGNMVTPQPNFQPINQQPAMPTKPAQPAFQPSPKTVVSA
PTVQTKTVTKTIADCVDGQHINIPRNPNTNAPDYSKISKGSYKGNTYKVN
KGDTMFLIAYLAGIDVKELAALNNLSEPYNLSLGQVLKISNCGTKTVTTT
VSVKQPAVTASTAMPAKPAVTYTPGANGTQIGSDGTIIGPIKSEAGISSS
VSVATSSTQVTSSVNNANSTPINANVVAPIASNVAWQWPTSGNIIQGFSS
TDGGNKGIDISGSRGQAVKAAAAGRIVYAGNALRGYGNLIIIKHNDDFLS
AYAHNDKILVADQQEVKAGQDIAKMGSSGTNTVKLHFEIRYKGKSVDPVR
YLPKR
>NTHI0926 lpsA, lipooligosaccharide glycosyl transferase
MKISMIFLPHFLYYTVPTFYLFGLLIMHNAAQHNYVISLTTEQKRRKHIT
DEFGKQNIPFEFFDAITPDIIEETAKKFNIALDRSPKAKLSDGEIGCALS
HIVLWDLALENNLNYINIFEDDIHLGENAKELLEIDYISDDIHVLKLEAN
GKMFFKQPKSVKCDRNVYPMTVKQSGCAGYTVTAKGAKYLLELVKNKPLD
VAVDSLVFEDFLHFKDYKIVQLSPGICVQDFVLHPDNPFESSLQEGRDRV
HGNQRKFSILEKIKNEFGRVKIKMFGKQVPFK
>NTHI0383 lpt6, PE-tn-6--lipooligosaccharide phosphorylethanolamine transferase
MIAYIFLALFTIAAVIFIVNSHYRWTYFFAITLFTFLFGGMLMVSSQWQR
ALNFSSVLFVVLMLFHRLKIHYYKQPLLISDFFLVVDWRNWETLIHYKGA
LFGVIGLLALLGYAIFGFNDVESLGVLGNSIGALLFIVSFSLMWHYSKNP
SAVQVWLDSLPDDGRDVFLNLPMSCRGIFFKVPNFDGNSQNFIEKMTALS
SDTNNLSETKPDIVVTLMESTLNPHQFAFSQQSIPPLSMFESQSDTVFAS
PLRVHTFAGATWKSEFAFLAGVPSTDFGALASGVFYSVVPHLQSGLVKNL
KAQGYFCVALSPFTKGNYNAKSAYDHFGFDLMLQPQDLGYPAPISKNLWD
ISSEEMMKYTRMILEKQHPALENVDQPMFVYVLTMREHGPYELGMENIFN
LQMPNLGAKSISALNDYTQRIVALNDAIEGMNNYLQERKKPFVLGYFGDH
QVAFDNAIPPKKGDYAQPDYVTQFVVRSNYASQFKQEQKFLDLAFAGGVL
MNVAGLSAEDEFMKANMAMCKLSHGKLEDSSDIQLLNDYRHYLYQTLAIA
R
>NTHI1222 lpxA, acyl-[acyl-carrier-protein]--UDP-N- acetylglucosamine O-acyltransferase
MIHPSAKIHPTALVEEGAVIGEDVFIGPFCIIEGSVEIKARTVLKSHVVV
RGDTVIGEDNEIYQFASIGEVNQDLKYKGEATKTIIGNSNRIREHVTIHR
GTIQGCGVTSIGNNNLLMVNVHVAHDCQIKNNCILANNATLAGHVELDDF
VIVGGMSAIHQFVIVGAHVMLGGGSMVSQDVPPYVMAQGNHARPFGVNLE
GLKRRGFDKPTMHTIRNIYKMLYRGGKTLEEVLPEIEQIAETDSAISFFV
EFFKRSTRGIIR
>NTHI1220 lpxB, lipid-A-disaccharide synthase
MNKTNPTIALVAGEVSGDILGAGLIRQLKAHYPNARFIGIAGTRMLAEGC
KTLVDMEELSVMGLAEILKHLPRLLKIRKNVIQTMLQEKPDVYIGIDAPD
FNLDVELKLKANGIKTIHYVSPSVWAWRQNRIHKIAKATHQVLAFLPFEK
AFYDKFNVPCRFIGHTMADAIPLKPNRAEACQMLQIDPAQRYLAILVGSR
GSEVEFLAEPFLKTALLLKEQFPDLQFLVPLVNEKRRIQFEAIKAKIAPN
LDLHLIDGNARQAMIAADATLLASGTAALEAMLCKSPMVVGYRMKPLTYF
LAKRLVKTDYISLPNLLANEMLVPEMIQEECTPELLAEKLSAYLSDDESA
VKNRHILIQHFTDLHQKIQCNADKQAAQAVIDLLEGTENV
>NTHI1312 lpxC, UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
MIKQRTLKQSIKVTGVGLHSGNKVTLTLRPAMPNTGVVYYRTDLNPAVAF
PADPNSVRDTMLCTALINDQGVRISTVEHLNAALAGLGIDNIIIEVDAPE
IPIMDGSASPFIYLLLDAGIEEQNAAKKFIRIKEYVRVEDGDKWAEFKPY
NGFRLDFTIDFDHPAIGKDVRNYEMNFSAQAFVHQISRARTFGFMKDIEY
LQSQGLALGGSLDNAIVLDDYRILNEDGLRFKDELVRHKMLDAIGDLYMA
GYNIIGDFKAYKSGHGLNNKLLRAVLANQEAWEFVTFEDKEQVPQGYVAP
AQVLI
>NTHI1082 lpxD, UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase
MQKSYSLQELATQIGATVRGNADVVVENIAPLDKAQSNQLTFISNVKFRA
LLKDSKAGILVVSEEDVEHCSPESNLLIVKDPYVAYAILAQYMDSTPKAA
QGIAKSAVIFDGVLLGENVSIGANAVIEEGVVLGDNVIIGANCFVGKNTK
IGSGTQLWANVTVYHNVEIGANCLIQSGTVIGSDGFGYANDRGRWIKIPQ
VGQVIIGNNVEIGANTCIDRGALDATIIEDNVIIDNLCQIAHNVHIGTGT
AVAGGVIMAGSLTVGRYCLIGGASVINGHMEICDKVTITGMGMVMRPITE
PGVYSSGIPLQTNKEWRKTAALTLGIDGINKRLKALEKKIS
>NTHI0069 lpxK, tetraacyldisaccharide 4'-kinase
MPFWYSNSKLIWLLSPFSLLFWLISQLRHALFCLGIKSSYRAPKPVIIVG
NLSVGGNGKTPVVVWLVEELKKRGLRVGVISRGYGSKSKTYPLFVTENTR
PIEGGDEPVLIAKRTNAPVVISPNRQQAIELLLSQAECDIIVSDDGLQHY
KLQRDLEIVVMDAERALGNGFVLPAGPLRELPSRLKSVDFVITNGGKNQY
SDAVMYLVPHFAINLKTNEKRQLKEFQSGVAIAGIGNPQRFFTMLEKLGI
QLERTQAFQDHQHFEASQLEKLAENQPLFMTEKDAVKCQSFANDNWWYVP
VDAEIIEAEKQCENLPHFWDKIDKLVAQYRNG
>NTHI2005 lsgC, putative UDP-galactose--lipooligosaccharide galactosyltransferase
MKKIGFFIMNIESAGGTERVSINVVNALAKQGYDVSFISIGGNKPFFQVD
EKINIYPMNKLPYSLKKDYFSITKKLRELVKELQLDTLIVVDGAIMLFSA
LALVNLNIKHILWEHYSFNFTGNRLVRTLGKYLAVTTCDKIVTLTEAEKT
LWQEKFKTNNIISIANPNTLLPKNKLAKWENKTVLSVGHLFSYKGFDYLL
KVWQVLAKKYPDWNLKIAGSGEEEENLKNLAKALNIEDSVNFIPRTNDVA
FYYESSSIYCLPSQTEGLPLVVIEAMAFGLPIVAFNCSPGVKQLVEHKEN
GFLCEQNNIEEMVKGLDLLINNPELYQQMSDKSRLMSEDYGIEKIIEEWK
GIL
>NTHI2004 lsgD, putative UDP-glcNAc--lipooligosaccharide N-acetylglucosaminyl glycosyltransferase
MLKKYLISLDKDIQRRKLFFSQKNTEDFQIFSAINTMQKDWDELASIFNI
EQFKAHYFRNVTKGEIGCTLSHLSVYQKIIEDNDIAEDSYALVCEDDALF
HSDFQQNLTALLSEKLEAEIILLGQSKINNFNDTDLEINYPTTFSFLCKK
TGNVNYAFPYKSYFAGTVGYLIKKSAARRFIQQISQNKPFWLADDFLLFE
QNFNIRNKVVRPLMVIENPVLISNLESVRGSLSNNLLKKLMKYPLKKIFA
IKKNLAN
>NTHI2003 lsgE, putative UDP-galactose--lipooligosaccharide galactosyltransferase
MLSIIVPSYNRKAEVPALLESLTQQTSSNFEVIIVDDCSKERVVVEQSYS
FPVTVIRNETNQGAAESRNVGARTSKGDWLLFLDDDDRFMPEKCEKILQV
IEQNPDINFIYHPAKCEMVNEGFTYVTQPIEPQEISTERILLANKIGGMP
MVAIKKEMFLKIGGLSTALRSLEDYDFLLKLLQEPSFTPYKINEPLTYCT
FHTKRSSVSTDTTNTQKAIDYIREHYVKTVEQARNFDINASYILAYPHIM
NLSRKAAKYYFDIFKKTKSIRQFIITLVILISPKLAINLKRLGK
>NTHI2002 lsgF, putative UDP-galactose--lipooligosaccharide galactosyltransferase
MKFSVLMSLYIKENPQFLRECFESLVAQTRQADEIVLVFDGVVTPELESV
VTEFETKLPLKLVKLPQNRGLGKALNEGLLHCTYDWVFRMDTDDICVPDR
FEKQVAFIEQHPESIIFGGQIAEFGKNVNDIVAYRNVPTSAQEIIKFTQK
RCPFNHMTVAYQKSAVINCGGYEDLQEDYYLWIKLVAQGLYMANLPDILV
YARVGNGMVSRRRGVNQAKAEWRLFKLKYRLGIQGLLSGLFTFALRFGSR
LLPTSLLKKLYQTFLRK
>NTHI1181 lspA, lipoprotein signal peptidase
MSKKSGLSFLWLSAVAFVVDLLTKYIVVQKFDLYESVNVLPVFNLTYVRN
YGAAFSFLADHSGWQQYFFILLALAISGMLVYFLAKNNAEQKIQNSAYAL
IIGGALANMVDRTYNGFVVDFFDFYWDIYHYPVFNIADIAICIGAGLLAL
DAFKSEKKKVQDKQVEKCGQK
>NTHI0294 mepA, penicillin-insensitive murein endopeptidase
MNKILLKTTIIFTALFSLNVVASPLDWQKVKRPIPSDDGKAKPIGSYTNG
CIIGAQALPPKGDGYQVIRMNRNRYYGHPNMIQYIERLGQRAKAAGLPTM
LVGDIAMPGGGRFLTGHASHQMGLDADIWLRMGEMSDADALNSDGKGLLV
VDRKAQRVDERVWNSNHATLIKLAAQDPNVTRIFVNPAIKVKLCQTAGND
RGWLHKVRPWYGHNSHFHVRLTCPADASYCENQAPVPAGDGCGDELYSWF
EPPKPGASVSKPKVTPPEPFLCQQILNSPNRSEWLE
>NTHI0205 mltA, membrane-bound lytic murein transglycosylase A precursor
MSVCKPFWFKTFSISIITALLVSCTSNIKNIQIPTTLNGSDPQQFGAKYT
NRTYQQAALVPVSNIENQSAVINQGDFLTQLSNIKNYSSKLSTNFYDNYE
KITNWVLSGANINELTQFNIHPQIMRGFDGYQNVLMTGYYSPILYARHTP
QGQFKNPIYRMPVKKRLSRAQIYAGALTGKRLELAYSDSMLENFLLGVQG
SGYVDFGDGNLNYFAYAGQNGYPYTAIGRLLVEDGEIPKEKMSIQAIREW
GNRNPSRVQSLLERNEAYVFFKNDPSGKVKGSAGVPLVAMASVASDRNII
PSGSVLLVEVPDIDNNGNWIGTHKLHLMVALDVGGAVKGHHFDLYRGIGA
RAGHIAGLSKHYGRVWVLR
>NTHI0921 mltC, membrane-bound lytic murein transglycosylase C precursor
MKKYLLLALLPFLYACSNSSNQGINYDEAFAKDTQGLDILTGQFSHNIDR
IWGVNELLVASRKDYVKYTDSFYTRSHVSFDEGNIVIETQQDLNRLHNAI
VHTLLMGADAKGIDLFTSGDVPISSRPFLLGQVVDHQGQQIANQVIASNF
ATYLIQNKLQTRRLQNGHTVQFVSVPMIANHVEVRARKYLPLIRKAAQRY
GIDESLILGIMQTESSFNPYAISYANAIGLMQVVPHTAGRDVFAMKGKGG
QPSTRYLYDPANNIDAGVSYLWILQNQYLDGITNPTSKRFAMISAYNSGA
GAVLRVFDNDKDTAIYKINQMYPEQVYRILTTVHPSSQARNYLLKVDKAQ
KKFRVRR
>NTHI0210 mpl, UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl- meso-diaminopimelate ligase
MKHIHILGICGTFMGGVAMIAKQMGYHVTGSDTNVYPPMNTFLEEQGIEI
IPNYDVAQLQPAPDMVIVGNAMKRGNPCVEYVLENNLKYTSGPQWLHDHL
LRDRWVLAISGTHGKTTTTGMLTWILEQNGLKPGFLIGGIAGNFGISARL
GDSPYFVIEADEYDTAFFDKRSKFVHYNPRTLIVNNISFDHADIFDDLKA
IQRQFHHMIRTIPASGLVLSSASEQSAKETLALGCWSQQQFLGKDNEWFA
ERITNDASHFAVFHHGEKVAEVKWNVVGQHNMHNALMAIAAAHHTGVAIE
DACKALGSFVNAKRRLEVKGEVNGITVYDDFAHHPEAILATLTALRDKVG
GVRILAVLEPRSNTMKMGVHKDDIAPALGRADAVFMLQPEQLSWEVADIA
NQCVQPAYWNANLDRLVDMIVAEAQPTDHILVMSNGSFGGIHQKILDKLK
LK
>NTHI1297 mraW, predicted S-adenosylmethionine-dependent methyltransferase involved in cell envelope biogenesis
MNSENSFSSSEHITVLLHEAVNGLALKENGIYIDGTFGRGGHSRFILSQL
SSNGRLIAVDRDPRAIAEAHKIQDLRFQIEHNSFSHIPEICDKLNLVGKI
DGILLDLGVSSPQLDEAERGFSFMKDGPLDMRMDTTQGLSAEEWLKQVSI
EDLTWVLKTFGEERFAKRIATAIVDFNKSAVKNSTEFLSRTSQLAELISQ
AVPFKDKHKHPATRSFQAIRIFINSELDELESLLNSALDMLAPEGRLSII
SFHSLEDRMVKHFMKKQSKGEDIPKGLPLREDQIQRNQKLRIIGKAIQPS
DAEIQANPRSRSAILRVAERI
>NTHI1302 mraY, phospho-N-acetylmuramoyl-pentapeptide-transferase
MLVWLAEYLVRYETAFNAISYITVRAILALLTALFISLWIGPKVIKRLQI
LKFGQEVRNDGPESHFAKKGTPTMGGVMILFSIGVSTLLWANLANSYIWV
CLFVLFGYGAIGFVDDFRKITRKNTDGLIARWKYFWMSVVALVAILWLYW
LGHDTDATRLVIPFFKDIMPQLGLFYIVLSYFVIVGTGNAVNLTDGLDGL
AIMPTALVAGAFALIAWATGNVNFAEYLHIPYIKYSSEVVVFCTAIVGAS
LGFLWFNTYPAQVFMGDVGSLALGGALGVVAILVRQEFLLVIMGGVFVVE
ALSVILQVGSYKLRKQRIFRMAPIHHHFELKGWPEPRVIIRFWIISLMLV
LMGLVTLKLR
>NTHI0567 mrcA, penicillin-binding protein 1A
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLRTVELQQPMQI
YTADGKLIGEVGEQRRIPVKLADVPQRLIDAFLATEDNRFYDHHGLDPIG
IARALFVAVSNGGASQGASTITQQLARNFFLTPEKTIIRKAREAVLAVEI
ENTLNKQEILELYLNKIFLGYRSYGVAAAAQTYFGKALNELTLSEMAIIA
GLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEYDAALKEPIVA
SYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRSGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFI
PAAVIEIAKGGADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRA
NGEWQLGQIPAANSALVSLNSDNGAIEAVVGGFSYEQSKFNRATQSLVQV
GSSIKPFIYAAALEKGLTLSSVLQDSPISIQKPGQKMWQPKNSPDRYDGP
MRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQYFASEALALG
AASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPEL
PELQSNFTALKEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTA
IYGEQGLDWKGTSWRIAQSIKRSDIGGKTGTTNSSKVAWYAGFGANLVTT
TYVGFDDNKRVLGRGEAGAKTAMPAWITYMKMALSDKPERKLPLPPKIVE
KNIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYYVPTELQQRLN
NEGNTPATQPQELF
>NTHI2031 mrcB, penicillin-binding protein 1B
MTSQHSAKKSSKNTPKNNRTFKGFLLKFSFTALVLTIFYGGYLDWQIRSK
MDGQIWHLPAEVYSRLESVKIADNLAFDEVIQILLDNEYRQTTMVAAPGD
FKLEDDSIVILRRAFPFPDKAEPQRVLRLRFSHNKLSRIEDLVTVKTVDE
FRLAPKLIAMLQSDNEDRLAIPLQNYPRLLIDTLILTEDRRFYEHNGINP
VGILRALIANIRAGQTVQGGSTLTQQLVKNLFLSRERTITRKANEALMSL
VLDWRYDKNRILETYLNEIYLGQNGDTQIHGFELASQFYFGRSIREISLD
QIALLVGMVKGPSLYNPWRNPQNALERRNIVLRLMLEHKMIGDELYQLLS
QRPLGVQKKGQISRKYPAFIQTLQADLRRELGEHKISSLLGARIFSTMDL
KQQAQAENAVVNTVSQLQLKMKNPHLEGAMIITDYRTGEIRAVVGGLQTQ
YAGFNRALMAKRQIGSLVKPSIYLTALSNPEQFRLNTPINNQPITINVKG
SPPWQPRNYDKKYSDSVMLMDALARSLNIPTVNIGMKVGLSKVIDTQKAM
GWDNVEIPKVPAMLLGSYSISPYDVTKLYQTLANQGGRIALTTVDSIADR
QGNLIFQHDKSAKQVVPQEAAFQTLFAMQQTVERGTARSLQKDYADLHLA
GKTGTTNESRDTWFVGIDGKNISTVWLGRDDNGETKLTGASGALQIYKDY
LNRTNIEKLAITPPTTVKWVGINQYGDWDCESYRTIPVWLNNGQNFCGET
SSPSLTPTTETETPPQESLWDVLDNPNPPAQ
>NTHI0039 mrdA, penicillin-binding protein 2
MNLKKFFNTPTHEPFRDKKAERNLFARRTLVAFLGILLLTGVLFTNIYQL
QIVNFDTYRTRSNGNRIKLLPLPPTRGLIYDRYGKLLAENLTFFGLYIVP
EKTENLDRTLDELRYIVGLTDNDIEHFKKERLRGTRYTPILLKPNLTEEQ
ISRFAVNGYQYPSLEVRPYFKRHYLYGETMAHILGYVGKMNDKDVERLKR
EDKFANYAGTNDIGKLGIERYYEDILQGTTGFEEVEINNRGKVIRTLRSR
PAVAGKSIHLTIDLALQRYITELLSGLKGAVVVLDPKDSSVLAMVSTPSY
DNNLFVDGISSEDYKRLLNDPARPLYSRATQGAYPPASTVKPFIAVAAQT
ENVITPNTTIFDPGYWVLPNSTKRFRDWKKTGHGDTDLNKAITESSDTYF
YQVAYNMGIDRLSNWMKDFGFGMPTGIEIQEETAANMPTREWKQKRYKRP
WVQGDTISVGIGQGYWTATPLQVAKATTILVNNGKVNTPHLMKAIEGAVL
EPYEDPLIYPDISTPKVTAWEAAKRGMYNVVNAANGTGRKAFADANYRVA
GKSGTAQVFSLKENEKYNAVGLKKELHDHAWFTAYAPYENPRLVVTVILE
NAGGGSSNAAPLARKVMDYYLNQRLPQVEKYNVPIQQKKDLSQESEQING
R
>NTHI0046 mreC, rod shape-determining protein MreC
MKPIFGKAPPLGIRLLIAIFASIALILADGRNSSITKARSAMETAIGGLY
YLANSPRSILDGISENLVDTNKLQIENKVLRQQLLEKNADLLLLDQLKVE
NQRLRLLLNSPLRTDEYKKIAEVLTAETDIYRQQIVINQGKKDGAYVGQP
VIDEKGVIGQIISVGENTSRVLLLTDVTHSIPVQVLRNDVRVIASGTGHT
DELSLDNVPRSVDIEKGDLLVTSGLGGRFLEGYPVAVVQSVSRDSSNYFA
IVKAKPLALLERLRYVLLLWPSNLDISKVKSMSPEEVRNLVQKRLESQAN
EANYRVKKTPLTEKDFLENEEKTIIEPDIPTDFLQNEEDLPIEQQEERIE
D
>NTHI0047 mreD, rod shape-determining protein MreD
MQTRFILQWFTILSFFVIAFVLELAPWPVGFQMLKPAWLVLVLLYWVLAI
PNKVSIGWSFLLGLTWDLILGSTLGVHALVLSTSMYIIAKNYLILRNLSL
WFQSLLVVLFVFIIRLLIFLVEFSLHTAFFHWQAILGAFASGLLWPWVFL
LMRKIRRKVKLH
>NTHI0296 msbB, lipid A biosynthesis (KDO)2-(lauroyl)-lipid IVA acyltransferase
MSDNQQNLRLTARVGYEAHFSWSYLKPQYWGIWLGIFFLLLLAFVPFRLR
DKFAGKLGIWIGHKAKKQRTRAQTNLQYCFPHWTEQQREQVIDKMFTVVT
QVMFGIGEIAIRSKKHLQKRSEFIGLEHIEQAKAEGKNIILMVPHGWAID
ASGIILHTQGMPMTSMYNPHRNPLVNWLWTIARQRFGGKMHARQNGIKPF
LNHVRKGEMGYYLPDEDFGVEQSVFVDFFGTYKATLPGLNKMAKLSKAVV
IPMFPRYNAETGKYEMEIHPAMNLSDDPEQSARAMNEEIESFVTPSPEQY
VWILQLLRTRKDGEDLYD
>NTHI0721 mscL, large-conductance mechanosensitive channel
MNFIKEFREFAMRGNVVDMAIGVIIGSAFGKIVSSLVSDIFTPVLGILTG
GIDFKDMKFVLAQAQGDVPAVTLNYGLFIQNVIDFIIIAFAIFMMIKVIN
KVRKPEEKKTAPKAETLLTEIRDLLKNK
>NTHI0997 mtgA, monofunctional biosynthetic peptidoglycan transglycosylase
MVQQKIANLLQGDFRYQIQYNWVSLENISPNIQLAVISSEDQRFFEHLGF
DFEAIQRAIRYNEKSNKGIRGASTISQQTAKNLMLWHGQNWLRKGLEVPA
TMLLELTWSKKRILEVYLNIAEFGNGIFGVEAASRYYFKKSAKNLSQNEA
ALLAAVLPNPIIYKVNKPSLLVRKKQTWILRQMGNLGTEYLSDL
>NTHI1244 murA, UDP-N-acetylglucosamine1-carboxyvinyltransferase
MDKFRVYGQSRLSGSVNISGAKNAALPILFAAILATEPVKLTNVPELKDI
ETTLNILRQLGVIANRDETGAVLLDASNINHFTAPYELVKTMRASIWALA
PLVARFHQAQVSLPGGCSIGARPVDLHISGLEKLGADIVLEEGYVKAQVS
DRLVGTRIVIEKVSVGATLSIMMAATLAKGTTVIENAAREPEIVDTADFL
NKMGAKITGAGSDHITTEGVERLTGCEHSIVPDRIETGTFLIAAAISGGR
VVCQNTKADTLDAVIDKLREAGAQVDVTENSITLDMLGNRPKAVNIRTAP
HPGFPTDMQAQFTLLNMVAEGTSIITETIFENRFMHIPELIRMGGKAEIE
GNTAVCHGVEQLSGTEVIATDLRASISLVLAGCIATGETIVDRIYHIDRG
YEHIEDKLRALGAKIERFSRSDEA
>NTHI0375 murB, UDP-N-acetylenolpyruvoylglucosamine reductase
MQNLQPFHTFHIQSNAREIIEAHSIEQLQQVWANSKSENLPVLFLGQGSN
VLFLDDFNGVVVLNRLMGITHEQDANFHYLHVNGGENWHKLVEWSINNGI
YGLENLALIPGCAGSAPIQNIGAYGVEFKDVCDYVDVLNLNTNETFRLDT
EQCEFGYRESTFKHRYQQGYVITAVGLKLKKDWQPILKYGSLVDFDPKTI
TAKQIFDEVCHIRQSKLPDPNETGNAGSFFKNPVVSSEHFEEIKKHHKNL
PHFPQADGSVKLAAGWLIDQCNLKGFQIGGAAVHKKQALVLINKSGATGQ
DVVKLAHHVRQTVAEKFGVYLQPEVRFISATGEVNSEQIIT
>NTHI1307 murC, UDP-N-acetylmuramate--L-alanine ligase
MKHSHEEIRKIIPEMRRVQQIHFIGIGGAGMSGIAEILLNEGYQISGSDI
ADGVVTQRLAQAGAKIYIGHAEEHIKGASVVVVSSAIKDDNPELVASKQK
RIPVIQRAQMLAEIMRFRHGIAVAGTHGKTTTTAMISMIYTQAKLDPTFV
NGGLVKSAGKNAHLGASRYLIAEADESDASFLHLQPMVSVVTNMEPDHMD
TYEGDFEKMKATYVKFLHNLPFYGLAVMCADDPVLMELVPKVGRQVITYG
FSEQADYRIEDYEQTGFQGHYTVICPNNERINVLLNVPGKHNALNATAAL
AVAKEEGIANEAILEALADFQGAGRRFDQLGEFIRPNGKVRLVDDYGHHP
TEVDVTIKAAREGWGDKRIVMIFQPHRYSRTRDLFDDFVQVLSLVDALIM
LDVYAAGEAPIVGADSKSLCRSIRNLGKVDPILVSDTSQLGDVLDQIIQD
GDLILAQGAGSVSKISRGLAESWKN
>NTHI1303 murD, UDP-N-acetylmuramoylalanine--D-glutamateligase
MNAYQNKNITIIGLGKTGLSCVDYLLSQQANIRVIDTRKKPTGIDKLPQN
IPLHTGSLNQEWLLESDMIVISPGLAVKTPEIQTALKAGVEVIGDIELFC
RAATKPIVGITGSNGKSTVTTLVYEMAKAAGVKVGMGGNIGIPALSLLNE
DCELYVLELSSFQLETTYSLKAAAATVLNVTEDHMDRYMDLEDYRQAKLR
IYHNAEVGVLNNEDKLTFGEGENQARQTVSFAENSADYWLKTENGKQYLM
VKDEVILPCEEVTLVGRHNYMNILAATALAQAVGINLDSIRTALRHFKGL
DHRFQLVHQANGIRWINDSKATNVGSTVAALAGLYIEGKLHLLLGGDGKG
ADFSELAELINQPHIICYCFGRDGVQLAKFSSQSYLFETMEQAIEFLRPT
LQSGDMVLLSPACASLDQFASFEKRGEEFTHLAQYSA
>NTHI1300 murE, UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6-diaminopimelate ligase
MKKLTALFNLPELKNDIELHNMVLDSRKVKAGDLFVAIKGHQVDGNQFID
SALHSGASAVVSETELSSEHLTVAFIRNVPVVKYYQLARHLSSLADVFYD
SPSKNLTLVGVTGTNGKTTISQLLAQWAELLGHRAAVMGTIGNGLLGQIV
EAKNTTGSAVEIQSSLSTFKHAGADFTSIEVSSHGLAQHRVEALHFKAAI
FTNLTRDHLDYHQSMENYAAAKKRLFTELDTQIKVINADDEIGYQWLTEL
PDAIAVSMNADFKVGSHQWMKAINIHYHFKGADITFESSWGNGVLHSPLI
GAFNVSNLLLVMTTLLSFGYPLENLLATAKSLKGVCGRMEMIQYPNKPIV
IVDYAHTPDALEKALIAAREHCQGELWCIFGCGGDRDRGKRPLMAQVAEQ
FAEKIIVTKDNPRTEPQSQIEADIVAGFKNMEKVGIIPDRAQAIQFAIES
AVENDVILIAGKGHEHYQIIGSEVVHFSDQEIALDFLK
>NTHI1301 murF, UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D- alanine ligase
MIKLSTVQLAQILQAKLIGDENVQVEEINTDTRKSVSNSLFFALKGEKFD
AHQYLDQAVSQGALALVVQQENSSILVPQLVVKDTRIALGELAKWLREKI
NPRTVAMTGSSGKTTVKEMTASILQHTAADSEAVLFTNGNFNNDIGVPLT
LLRLTEKHRFAVIELGANHQNEINYTTKLVQPNAALINNIAPAHLEGFGS
LAGVVQAKGEIYRGLTKNGVAIINAEHNHLDIWQKEISNHAIQYFNGKDY
SVKNVQGNEQGSTFTLVSPQGEIDISLPYLGEHNVKNALAATALAMNVGA
TLADVKAGLEQRSQVKGRLFPIQVTPNLLLLDDTYNANKDSLCAAIDVLK
SYDAFLILCVADMKELGENSLAIHREVGQYVNLVNLDLVCSYGNESAVIS
EAVLGKHFTDKTEMVDFLVPLIENQLQQNKKVVVLGKGSRSMKMEDVIYS
LKDKIKC
>NTHI1305 murG, UDP-N-acetylglucosamine--N-acetylmuramyl- pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKNKKLLVMAGGTGGHVFPAIAVAQTLQKQEWDICWLGTKDRMEAQLVPK
YGIPIRFIQISGLRGKGIKALLNAPFAIFRAVLQAKKIIQEEKPDAVLGM
GGYVSGPAGVAAKLCGVPIILHEQNAIAGLTNKLLGKIATCVLQAFPTAF
PHAEVVGNPVREDLFEMPNPDIRFSDREEKLRVLVVGGSQGARVLNHTLP
KVVAQLADKLELRHQVGKGAVEEVSQLYGENLEQVKITEFIDNMAEAYAW
ADVVICRSGALTVCEIAAVGVAAIFVPFQHKDRQQYLNAKYLSDVDAAKI
IEQADLTPEMLVNYLKNLTRENLLQMALKAKTMSMPNAAQRVAEVIKQYS
N
>NTHI2050 murI, glutamate racemase
MDKKEKRPTVLFFDSGVGGFSVYREAKKLLPNWHYLYCFDNAGFPYSERE
EESIIHRTLAACQLINQRYPLDAIVIACNTASTVVLPPLRAAFEIPIIGT
VPAIKPASEITKTKHIGLLATKGTVKRHYIDELIDKFAQDCIVERLGTTK
LVEIAEQKIRGHSVDLISLKDELSSWAGMADLDTLVLGCTHFPLIKDEIQ
LCLPQVKYFMDPSAAIAKRIKYLLDDKNLQVQNEKYNQMFCTAHFPEESQ
FKKALHLWGFESLEVIKID
>NTHI0228 nanA, N-acetylneuraminate lyase
MRDLKGIFSALLVSFNEDGTINEKGLRQIIRHNIDKMKVDGLYVGGSTGE
NFMLSTEEKKEIFRIAKDEAKDQIALIAQVGSVNLKEAVELGKYATELGY
DCLSAVTPFYYKFSFPEIKHYYDTIIAETGNNMIVYSIPFLTGVNMGIEQ
FGELYKNPKVLGVKFTAGDFYLLERLKKAYPNHLIWAGFDEMMLPAASLG
VDGAIGSTFNVNGVRARQIFELTKAGKLAEALEIQHVTNDLIEGILANGL
YLTIKELLKLEGVDAGYCREPMTSKATAEQVAKAKDLKAKFLS
>NTHI1954 nlpC, probable lipoprotein NlpC
MLKRILVIIGLAVLATACSNAPRTVSHQVISENDDIQLTGLINNLEKDNR
TGIFHKVRTNRSSALMGDKALASVYNEWVGTRYRMGGTTKRGIDCSAFMQ
TTFSEVFGIELPRSTAEQRHLGRKINKSELKKGDLVFFRKNNHVGVYIGN
NQFMHASTGQGVTISSLDEKYWARTYTQSRRIM
>NTHI0448 oapA, opacity associated protein OapA
MNSMDKNQQSSQNELDLGLNQEPITPKKTIQPSSSILGKAKGLFAKKNHV
QTNFQQRKEPTFGDSSTQENDPLIPSENLKKVQKPVLQTSSTEENISAVD
EEISAENNADEPVEKAEKPILAQPEKWKILQVLPAKHRRLFMAIFVLVIL
LIIFFALKPSSDTVESFTQSNSNEVPVQFQSLDQSQPLETTILDNPPAQN
QMAVEQANQSEFAPKAEEAANNTTAQNPLVENAPMQQNVVQSPSQMPNEM
AAASVMPMQPAQAEQPKATVPVQPMKKAVEPQVAHKDTVKKEVKVAENAQ
APSKATEQNVAKTAGNAPIVEAKPVQVKKEKKVQIVDAKPVSKSAASRLS
AKTLTVPKGVSLMQVFRDNQLNISDVNAMSKAAGAGNVLSSFKSGDKVTV
SVNNQGRVNEMRLSNGARFVRQSDGSYQYKK
>NTHI1083 omp26, Outer membrane protein 26
MKNIAKVTALALGIALASGYASAEEKIAFINAGYIFQHHPDRQAVADKLD
AEFKPVAEKLAASKKEVDDKIAAARKKVEAKVAALEKDAPRLRQADIQKR
QQEINKLGAAEDAELQKLMQEQDKKVQEFQAQNEKRQAEERGKLLDSIQT
ATNNLAKAKGYTYVLDANSVVFAVEGKDITEEVLKSIPASEKAQEKK
>NTHI0225 ompP2, Outer membrane protein P2 precursor
MKKTLAALIVGAFAASAANAAVVYNNEGTNVELGGRLSIIAEQSNSTIKD
QKQQHGALRNQSSRFHIKATHNFGDGFYAQGYLETRLVSAQSGTESDNFG
HIITKYAYVTLGNKALGEVKLGRAKTIADGITSAEDKEYGVLNNSKYIPT
NGNTVGYTFKGIDGLVLGANYLLAQERHKYTTAAGTRAVTVAGEVYPQKI
SNGVQVGAKYDANNIIAGIAYGRTNYREDIVDPDLGKKQQVNGALSTLGY
RFSDLGLLVSLDSGYAKTKNYKDKHEKSYFVSPGFQYELMEDTNVYGNFK
YERDSVDQGKKTREQAVLFGVDHKLHKQVLTYIEGAYARTRTTEQAKGVK
TEKEKSVGVGLRVYF
>NTHI1332 ompP5, Outer membrane protein P5
MKKTAIALVVAGLAAASVAQAAPQENTFYAGVKAGQGSFHDGINNNGAIK
QNLSSANYGYRRNTFTYGVFGGYQILNQDNFGLAAELGYDNFGRVKLREA
GKPKAKHTNHGAHLSLKGSYEVLDGLDVYGKAGVALVRSDYKFYEVANGT
RDHKKGRHTARASGLFAVGAEYAVLPELAVRLEYQWLTRVGKYRPQDKPN
TAINYNPWIGSINAGISYRFGQGEAPVVAAPEMVSKTFSLNSDVTFAFGK
ANLKPQAQATLDSVYGEISQVKSAKVAVAGYTDRIGSDAFNVKLSQERAD
SVANYFVAKGVAADAISATGYGKANPVTGATCDQVKGRKALIACLAPDRR
VEIAVNGTK
>NTHI1342 opa, opacity protein
MKKSLLAVIVGAFAFASVANANIYAEGDIGLSQTKANGSNNTRVEPRVSV
GYKVGNTRVAGDYTHHGKVDGTKIQGLGASVLYDFDTNSKVQPYVGARVA
TNQFKYTNRAEQKFKSSSDIELGYGVVAGAKYKLDGNWYANGGVEYNRLG
NFDSTKVNNYGAKVGVGYGF
>NTHI0368 opsX, ADP-heptose--lipooligosaccharide heptosyltransferase I
MPFFTEAPKSLCILRLSAVGDVCHALAVVQHIQAYYPQTEMTWIVGKTEM
GLLSGIPNITLIPYDKKAGWKGVLLFWKQLKNKQFDALLNMQTAFRASIL
SLGIKAKFKIGFGEKRSREGQWLFVNRRITDPFSPHVLDGFMAFAEYIGV
PKSEPKWELAISQDDDKFADQFIDFSRKNLLISPCSSKAEKDWLIERYAE
IANIAHQHNINVIFCSSPAKRELEIVEKITALCHFTPTNIAGKTNLKQLT
ALISKVDLVLSPDSGPAHIATTQGTPVIGLYAYHNPLRTAPYNNLDNVVS
VYEENAQKEFGKPSSELPWATKLKGKNLMAEIQVEPVIEQMKKLGLF
>NTHI0889 ostA, organic solvent tolerance protein
MNKKHTLISLAILTALYSQQSLADLHEQCLMGVPKFSGEVVTGDVNSLPV
YIEADNAEINQPNDATYQGNVDLKQGNRHLLAQSVQVKQSGNQSTPLRMA
YVRNGFDYKDNQINMLGKDAEFNLDSHDGNLTNSEYEFVGRQGRGKADNI
TLHNNYRVMKNATFTSCLHGDNAWAVDASEIRQYVKEEYAEMWHARFKIH
GVPVFYTPYLQLPIGDRRRSGLLIPSAGTSNRDGLWYAQPIYWNIAPNYD
LTFTPKYMSRRGWQANGEFRYLTSIGEGKVAGEYLGKDRYSEYASDNRKR
HLFYWNHNSSFLQNWRLNINYTRVSDKRYFNDFDSIYGRSTDGYANQYAR
IAYYQPNYNFSLSAHQFQIFDDIVNIGPYRAVPQLDFNYHKYDLANGWLN
FKLHSQAVRFDNDSKLMPTAWRFHAEPSLNSLMSNKYGSLNIETKLYATR
YEQKKGSGKNAEDVQKTVNRVIPQFKVDLQSVLSRDITFLKEYTQTFEPH
VQYLYRPYRNQSNIGSTLNNDYLGFGYDSALVQQDYYSLFRDRRYSGLDR
ISSANQVTLGGTTRFYDIAGEERFNLSAGQIYYLSNSRIDENPANKTPTS
SSAWALESNWKISNKWYWRGSYQFDTHTNSTSLANTSLEYNPEKNNLIQL
NYRYVNQEYIDQNLGKSANAYQQDIQQVGLVVGWEIANNWAVVGRYYQDL
ALQKPVEQYLGVQYNSCCWAASVGVKRNVTNHQNQTRNEIVYDNSIGITL
ELRGLGSNDHQSGIQEMLEKGKLPYIRAFSLD
>NTHI0501 pal, outer membrane protein P6 precursor
MNKFVKSLLVAGSVAALAACSSSNNDAAGNGAAQTFGGYSVADLQQRYNT
VYFGFDKYDITGEYVQILDAHAAYLNATPAAKVLVEGNTDERGTPEYNIA
LGQRRADAVKGYLAGKGVDAGKLGTVSYGEEKPAVLGHDEAAYSKNRRAV
LAY
>NTHI0483 pbpG, penicillin-binding protein 7 homolog precursor
MFKKALFILSLCPSFLLAQSYVVYDFTHNRVLESYAPDSIQPIASVTKLM
TANVFLENNKNPNCRIAITKEDTDRIKGTGTKLPKNIPISCNELLKAMLV
HSDNYAAHALSRAAGISRRQFINKMNEKAHQLGMYSTRFHDSSGLSSYNI
SSPMDLVKLAKYSLNKSDIKLLSNLSATYIQAGKHKLYIKNTNKLVRDEI
FDAAVNKTGYIRESGYNLVFINKHLCKNATIGVISLNNTSSAYRSSFTKS
KLEKFGCTALNGRTIRDVAGEAQYEDGYDEVGFNTLIQKLSR
>NTHI1473 pcp, Outer membrane lipoprotein PCP precursor
MKKKTLALAILTIFSVAGCTNTDIFSGDVYSASQAKEARSITYGTIVSVR
PVKIQADNQGVIGTLGGGALGGIAGSAIGGGRGQVIAAVVGAIGGAVAGS
KIEEKVSQVNGAELVIKKDDGQEIVVVQKADSSFVAGRRVRIVGGGSNLN
VSVL
>NTHI1969 prc, tail-specific protease precursor
MVMKFKMSKNVICYAWLSVCLSSAIPAFAVQPTLKPSDISIPAISEESQL
ATKRATTRLTQSHYRKIKLDDDFSEKIFDRYIKNLDFSHNTFLQSDIDEL
RQKYGTKLDEQLSQGDLSAAFDIYDVMMKRRYERYTYALSLLDKEPDLNG
QDQIEIDREKAAAPQTEADANKLWDARVKNDIINLKLKDKKWSEIKAKLT
KRYNLAIRRLTQTKADDIVQIYLNAFAREIDPHTSYLSPRTAKSFNESIN
LSLEGIGTTLQSEDDEISIKSLVPGAPAERSKKLHPGDKIIGVGQATGDI
EDVVGWRLEDLVEKIKGKKGTKVRLEIEPAKGGKSRIITLVRDKVRIEDQ
AAKLTFEKVSGKNIAVIKIPSFYIGLTEDVKKLLVKLENQKAEALIVDLR
ENGGGALTEAVALSGLFIADGPVVQVRDAYQRIRVHEDDDATQQYKGLLF
VMINRYSASASEIFAAAMQDYRRGIIIGQNTFGKGTVQQSRSLNFIYDLD
QSPLGVLQYTIQKFYRVNGGSTQLKGVAADINFPEIIDAKEYGEDKEDNA
LAWDKIPSASYTEVGNIDYIDNAVNILNEKHLARIAKDPEFVALNEELKV
RNERRDRKFLSLNYKMRKAENDKDDARRLKDLNERFKREGKKALKDIDDL
PKDYEAPDFFLKEAEKIAADFVIFNSDQKINQANGLSEAKTESKK
>NTHI1278 rfaD, ADP-L-glycero-D-manno-heptose-6-epimerase
MIIVTGGAGFIGSNIVKALNDLGRKDILVVDNLKDGTKFANLVDLDIADY
CDKEDFIASIIAGDEFGDIDAVFHEGACSATTEWDGKYIMHNNYEYSKEL
LHYCLDREIPFFYASSAATYGDTKVFREEREFEGPLNVYGYSKFLFDQYV
RNILPEAKSPVCGFRYFNVYGPRENHKGSMASVAFHLNNQILKGENPKLF
AGSEGFRRDFVYVGDVAAVNIWCWQNGISGIYNLGTGNAESFRAVADAVV
KFHGKGEIETIPFPEHLKSRYQEYTQADLTKLRSTGYDKPFKTVAEGVTE
YMAWLNRK
>NTHI1607 rfaE, ADP-heptose synthase
MAQYSAEFKQAKVLVLGDVMLDRYWFGATNRISPEAPVPVVRVQENEERA
GGAANVAMNIASLNVSVQLMGLIGQDETGSALSLLLEKQKIDCNFVALET
HPTITKLRILSRHQQLLRLDFEEDFNNVDCKDLLAKLESAVKNYGALILS
DYGKGTLKDVQKMIQIARKANVPVLIDPKGTDFERYRGATLLTPNMSEFE
AVVGKCNTEEEIIKKGLKLISDIELTALLVTRSEKGMTLLRPNQEPYHLP
TVAKEVFDVTGAGDTVISVLATALADGRSFEESCYLANVAAGIVVGKLGT
STVSTVELENAIHARPETGFGIMSEAELKDAVAQAKARGEKIVMTNGCFD
ILHPGHISYLENARKLGDRLIVAVNSDDSVKRLKGESRPINNLENRMAVL
AGLASVDWLVPFTEDTPQRLIGEILPDLLVKGGDYKPEEIAGSKEVWANG
GDVKVLNFENGCSTTNVIEKIKLLKD
>NTHI1272 rfaF, ADP-heptose--lipooligosaccharide heptosyltransferase II
MNILIIGPSWVGDMMMSHSLYQQLKIQYPNCNIDVMAPNWCKPLLARMPE
VRKAIEMPLGHGAFELGTRYRLGKALRNQYDMAIVLPNSLKSAFIPAFAK
IAVRRGWKGESRYFLLNDLRNNKRDYPMMVQRYVALAFEQNAVPKAADIP
VLKPYLTVDPTQQAETLKNFKKQTALLGERPIIGFCPGAEFGPAKRWPHY
HYAKLAEMLITQGYAVALFGSAKDEPVGEEIRQALPEALREFCVNLAGKT
NLNEAVDLIANCTAVVTNDSGLMHIAAAVNRPLIALYGPTSPQYTPPLSD
KATIIRLIEGGLIKVRKGDKEGGYHQSLIDITPEMALEKLNELLAK
>NTHI0037 rlpA, RlpA-like protein
MKLKTGLNLTALLLFMISVAFPAQADTQKMYGIRGDNLSIATQMPAPRTY
SVKGQTYTTKSGNEAKSYIKEGLASYYHLKFDGRKTASGDVYNSKQFTAA
HKTLPINSYALVTNLHNNRKVIVRINDRGPFSDKRLIDLSHAAAKEIGLI
SRGIGQVRIEALHVAKNGNLSGAATKTLAKQAKTQEAADRLVLKSNTLFD
NASKSINALKGTEFYCLKMLELTSHSQANKLITQLALANIQTEVNRSGNK
YEIYIGPFDDKTKMAQVRTKLQKMANNKPLIVYTYKN
>NTHI1037 rmlB, dTDP-glucose 4,6-dehydratase
MSNTNRTILVTGGAGFIGSALVHYLLEKTHNKIVNVDKLTYAGNLASLKT
VENHPRYAFVQADICDTKALSYIFSQYQPDAVIHLAAESHVDRSINASSE
FIQTNIVGTYCLLESTLDYWHRLDNQKKSSFRFLHISTDEVYGDLKSNEG
LFTETSAYKPSSPYSASKAASDHLVQAWYRTYGLPTIITHSSNNYGPYQY
PEKLIPLMILNAIEGKTLPIYGDGLQIRDWLFVEDHIDALYNVLMKGNIG
ETYNIGGNNEKSNIDVVRSICSLLEEFLPNKPKHIDKYEDLICYVQDRPG
HDLRYALDTSKINHKLGWIPKETFESGLRKTVIWYLNHQEWCQKVSE
>NTHI1891 siaB, acylneuraminate cytidylyltransferase
MTRIAIIPARAGSKGIKDKNLQLVGGVSLVGRAILAAQESGMFDQIVVTS
DGENILKEATKYGAKPVARPESLAQSDTRTIDAILHCLETLNISQGTAAL
LQPTSPLRNALDIRNAMEIFLGGKYKSVVSACECEHHPYKSFTLEGTEVQ
PIHELTDFEAPRQKLPKSYRANGAIYINDIESLFEEKRFFIAPMRFYLMP
TYRSIDIDSTLDLQLAESLISKEF
>NTHI0503 tolA, TolA
MQNNRQKKGINAFAISILLHFILFGLLILSSLYHTVEIMGGGEGEGDVIG
AVIVDTGTAAQEWGRIQQQKKGQADKQKRPEPVVEEKPPEPNQEEIKHQQ
EVQRQEEIKHQQEVQRQEELKRQQEQQRQQEIKKQQEQARQEALEKQKQA
EEARAKQAAEAAKLKADAEAKRLAAAAKQAEEEAKAKAAEIAAQKAKQEA
ETKAKLEAEAKAKAAAEAKAKAEAEAKAKAAAEAKAKAEAEAKAKAAAEA
KAKADAEAKAKAAAEAKAAAEAKRKADQASLDDFFNGGDVGGGSASKGGN
TNKGGTQGSGAALGSGDGGKVGDQYAGVIKKEIQRRFLKDPNFAGKVCRI
KIQLGRDGTILGYQKISGSDDICSAALSAVARTKKVPAAPSDEIYEKYKS
PIIDFDIR
>NTHI0358 tonB, TonB
MQQTKRSLLGLLISLIAHGIIIGFILWNWNEPSDSANSAQGDISTSISME
LLQGMVLEEPAPEPEDVQKEPEPEPENVQKEPEPEKQEIVEDPTIKPEPK
KIKEPEKEKPKPKEKPKNKPKKEVKPQKKPINKELPKGDENIDSSANVND
KASTTSAANSNAQVAGSGTDTSEIAAYRSAIRREIESHKRYPTRAKIMRK
QGKVSVSFNVGADGSLSGAKVTKSSGDESLDKAALDAINVSRSVGTRPAG
FPSSLSVQISFTLQ
>NTHI0849 vacJ, VacJ lipoprotein
MKTKVILTALLSAIALTGCANHNATKQASERNDSLEDFNRTMWKFNYNVI
DRYVLEPAAKGWNNYVPKPISSGLAGIANNLDEPVSFINRLIEGEPKKAF
VHFNRFWINTVFGLGGFIDFASASKELRIDNQRGFGETLGSYGVDAGTYI
VLPIYNATTPRQLTGAVVDAAYMYPFWQWVGGPWALVKYGVQAVDARAKN
LNNAELLRQAQDPYITFREAYYQNLQFKVNDGKLVESKESLPDDILKEID
>NTHI0649 waaQ, ADP-heptose--lipooligosaccharide heptosyltransferase III
MRFFYFSGEIMEKILVIRNDKLGDFMQAWPAFAMLKASNPELKLTALVPS
YTAPLAEICPFIDDVIIDSKKNDKTDFKRLVQEIKAQQFDGMISFFSNTH
NGKLAWKSGIKYRLAPATKWVQILYNHRLTQRRSRSEKSEAEYNQDLVRT
FLQKHNMPVVEPKPPYLIFEKSAVENQRVFLQESLGLSANKKWIFVHSGS
GGSATNLSLAQYADLIKGLLAEFDCNIVLTAGPGEREKAYELANLVNDLR
VAIYDKNKGLVDFAHSLACADLFIAGSTGPLHLSSAFNIPTIGFYPNSRS
SQPRRWKPINDVDKHLAFCPPAGKETQMNLELISIDNALAEISLFIRNMW
QTSNNI
>NTHI2025 wecA, undecaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase
MLSIFVTFLGAFLTLIVMRPLANWIGLVDKPNYRKRHQGTIPLIGGVSLF
VGNLCYYLMEWDQLRLPYLYLFSIFVLLAIGILDDRFDISPFLRAGIQAI
LAILMIDLGNIYLDHLGQILGPFQLTLGSIGLIITVFATIAIINAFNMID
GIDGLLGGLSCVSFAAIGILMYRDGQMDMAHWSFALIVSILPYLMLNLGI
PFGPKYKVFMGDAGSTLIGFTIIWILLLSTQGKGHPMNPVTALWIIAIPL
IDMVAIIYRRVRKGKSPFRPDRLHVHHLMVRAGLTSRQAFLLITFVSAVC
ATIGILGEVYYVNEWAMFVGFFILFFLYVYSITHAWRITRWVRRMKRRAK
RLKKA